Browse by Poster Presenter

Schedule at a Glance

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Presenter

Type here to filter the list

S
Sałamacha, Maciej

Maria Sklodowska-Curie National Research Institute of Oncology
(P 313) SIGNIFICANCE OF LYMPH NODE PROCEDURES IN SOFT TISSUE SARCOMA PATIENTS
Maciej Sałamacha
Favorite
Saade, Jamal

Hôpital Maisonneuve-Rosemont, Montreal, Quebec
(P 143) IMPACT OF SURGICAL MARGINS IN CHEST WALL CHONDROSARCOMAS: A CANSARCC STUDY
Jamal Saade
Favorite
Sabeth-Rashedi, Manije

German Cancer Society
(P 204) ANALYSIS OF QUALITY INDICATORS OF SOFT TISSUE SARCOMA TREATMENT WITH CANCER REGISTRY DATA IN GERMANY 2015-2021
Manije Sabeth-Rashedi
Favorite
Sabnis, Amit

UCSF Benioff Children's Hospital
(P 427) PHASE 1/2 TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF PEEL-224 IN COMBINATION WITH VINCRISTINE AND TEMOZOLOMIDE IN ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY SARCOMAS
Amit Sabnis
Favorite
Sachs, Elizabeth

Duke University
(P 84) A MULTICENTER COMPARISON OF REVERSE TOTAL SHOULDER ARTHROPLASTY VERSUS HEMIARTHROPLASTY FOR ENDOPROSTHETIC RECONSTRUCTION FOLLOWING ONCOLOGIC RESECTION OF THE PROXIMAL HUMERUS
Elizabeth Sachs
Favorite
(P 214) FINANCIAL TOXICITY IN PATIENTS WITH A HISTORY OF EXTREMITY AND PELVIC SARCOMA TREATMENT
Elizabeth Sachs
Favorite
Saita, Alberto

IRCCS Humanitas Research Hospital
(P 365) UROLOGICAL RECONSTRUCTION DURING RETROPERITONEAL AND PELVIC SARCOMA SURGERY: EXPERIENCE FROM A HIGH-VOLUME SARCOMA CENTER
Alberto Saita
Favorite
Sakai, Hideki

Hyogo Cancer Center
(P 192) OPTIMAL DOSING SCHEDULE OF SUNITINIB BASED ON PLATELET COUNT IN AN OLDER PATIENT WITH GASTROINTESTINAL STROMAL TUMOR
Hideki Sakai
Favorite
Sala, Alexandra

Dana-Farber Cancer Institute
(P 427) PHASE 1/2 TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF PEEL-224 IN COMBINATION WITH VINCRISTINE AND TEMOZOLOMIDE IN ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY SARCOMAS
Alexandra Sala
Favorite
Sala, Maria Angeles

Hospital Universitario Basurto
(P 389) UNRESECTABLE AND METASTATIC DEDIFFERENTIATED LIPOSARCOMA (DDLPS): INSIGHTS FROM A MULTICENTER REAL-WORLD COHORT (RWC)
Maria Angeles Sala
Favorite
Salawu, Abdulazeez

Princess Margaret and Mt Sinai Hospitals
(P 128) ISOCITRATE DEHYDROGENASE 1 (IDH1) MUTATION TESTING IN THE PHASE 3 STUDY OF IVOSIDENIB VS PLACEBO IN IDH1-MUTANT CONVENTIONAL CHONDROSARCOMA (CHONQUER)
Abdulazeez Salawu
Favorite
(P 346) SURROGATE ENDPOINTS FOR OVERALL SURVIVAL IN ADVANCED SOFT TISSUE SARCOMA TRIALS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Abdulazeez Salawu
Favorite
(P 395) ERIBULIN IN RECURRENT PRETREATED METASTATIC SOFT TISSUE SARCOMA. A CANADIAN SARCOMA RESEARCH AND CLINICAL COLLABORATION (CANSARCC) REAL WORLD ANALYSIS
Abdulazeez Salawu
Favorite
Salazar-Arcila, Carolina

University of Calgary
(P 238) INVESTIGATING HOW MACROPHAGES INFILTRATE THE TUMOUR MICROENVIRONMENT AND INFLUENCE THE EFFICACY OF CAR T THERAPY IN A MURINE MODEL OF STS
Carolina Salazar-Arcila
Favorite
(P 239) CHARACTERIZING THE ROLES OF T-CELLS IN THE CONTEXT OF TUMOR CLEARANCE AND MEMORY IN THE KP MODEL OF SARCOMA FOLLOWING STING THERAPY
Carolina Salazar-Arcila
Favorite
(P 378) HIGH DOSE RADIATION THERAPY PROMOTES IMMUNE SUPPRESSIVE MACROPHAGE PHENOTYPES, WHEREAS LOW DOSE RADIATION THERAPY PROMOTES IMMUNOGENIC MACROPHAGE PHENOTYPES IN A MURINE MODEL OF SOFT TISSUE SARCOMA
Carolina Salazar-Arcila
Favorite
Salazar, Juliana

Institut de Recerca Sant Pau (IR Sant Pau)
(P 71) GERMLINE POLYMORPHISMS IN THE VEGF PATHWAY AS PROGNOSTIC BIOMARKERS IN LOCALIZED HIGH-GRADE OSTEOSARCOMA: A STUDY BASED ON DATA FROM THE GEIS-33 PROTOCOL
Juliana Salazar
Favorite
Saldanha, Erick

Princess Margaret Cancer Centre
(P 346) SURROGATE ENDPOINTS FOR OVERALL SURVIVAL IN ADVANCED SOFT TISSUE SARCOMA TRIALS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Erick Saldanha
Favorite
Salehi, Mohammad Amin

Research Institute of the McGill University Health Centre (RI-MUHC)
(P 120) SURVIVAL OUTCOMES AND ROLE OF CHEMOTHERAPY IN PATIENTS OLDER THAN 40 YEARS WITH OSTEOSARCOMA (OLD-SARC STUDY).
Mohammad Amin Salehi
Favorite
Saleh, Mohammed

University of Miami Hospital, Department of Radiology
(P 201) METASTATIC PATTERNS, TREATMENT MODALITIES, AND OVERALL SURVIVAL IN OLIGOMETASTATIC GIST: A SINGLE-CENTER RETROSPECTIVE STUDY
Mohammed Saleh
Favorite
Saleh, Ramy

Cedars Cancer Center, McGill University Health Center
(P 120) SURVIVAL OUTCOMES AND ROLE OF CHEMOTHERAPY IN PATIENTS OLDER THAN 40 YEARS WITH OSTEOSARCOMA (OLD-SARC STUDY).
Ramy Saleh
Favorite
Saleh, Ramy

McGill University Health Center
(P 226) REAL-WORLD MANAGEMENT OF SYMPTOMATIC VS ASYMPTOMATIC TGCT FROM AN OBSERVATIONAL REGISTRY
Ramy Saleh
Favorite
Saleh, Ramy

Cedars Cancer Center, McGill University Health Center
(P 407) PIMICOTINIB IN TENOSYNOVIAL GIANT CELL TUMOR (TGCT): LONG-TERM EFFICACY, SAFETY, AND PATIENT-REPORTED OUTCOMES FROM THE PHASE 3 MANEUVER STUDY
Ramy Saleh
Favorite
Salib, Alice

Children's Cancer Institute
(P 11) ESTABLISHMENT, CHARACTERIZATION AND RESEARCH APPLICATION OF EIGHT NOVEL PATIENT-DERIVED OSTEOSARCOMA CELL LINES
Alice Salib
Favorite
Salinas, Melisa

Angel H Roffo Institute of Oncology
(P 386) RADIO-GUIDED SURGERY FOR NONPALPABLE SOFT-TISSUE SARCOMAS
Melisa Salinas
Favorite
Salvatore, Daniela

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
(P 210) TOWARDS INTERNATIONALIZATION OF THE CLINICAL RESEARCH COORDINATOR ROLE: THE FIRST DROP OF THE NIAGARA FALLS PROJECT
Daniela Salvatore
Favorite
(P 307) STRATEGIES FOR DATA QUALITY IN TARPSWG RETROPERITONEAL SARCOMA REGISTRY (RESAR)
Daniela Salvatore
Favorite
Samà, Laura

IRCCS Humanitas Research Hospital
(P 203) MINIMALLY INVASIVE RESECTION OF MULTIFOCAL DUODENO-JEJUNAL GISTS IN NEUROFIBROMATOSIS TYPE 1
Laura Samà
Favorite
(P 318) BURIED DE-EPITHELIALIZED FLAP RECONSTRUCTION AFTER WIDE EXCISION OF THIGH SARCOMAS: EARLY EXPERIENCE FROM A SPECIALIZED SARCOMA SURGERY UNIT
Laura Samà
Favorite
(P 328) INNOVATING SARCOMA EDUCATION: EARLY OUTCOMES OF THE ITALIAN SOCIETY OF SURGICAL ONCOLOGY (SICO) SARCOMA SOCIAL MULTI-PLATFORM JOURNAL CLUB INITIATIVE
Laura Samà
Favorite
(P 339) POSTERIOR APPROACH FOR RADICAL RESECTION OF SACROCOCCYGEAL CHORDOMA: A SURGICAL PERSPECTIVE FROM A TERTIARY REFERRAL CENTER
Laura Samà
Favorite
(P 365) UROLOGICAL RECONSTRUCTION DURING RETROPERITONEAL AND PELVIC SARCOMA SURGERY: EXPERIENCE FROM A HIGH-VOLUME SARCOMA CENTER
Laura Samà
Favorite
Sam, Xin Xiu

Singapore General Hospital
(P 53) ESTABLISHMENT AND CHARACTERISATION OF LIPOSARCOMA-DERIVED CELLS AS RELEVANT PRE-CLINICAL MODELS FOR TARGET DISCOVERY
Xin Xiu Sam
Favorite
San Martin, Gabriela

Angel H Roffo Institute of Oncology
(P 386) RADIO-GUIDED SURGERY FOR NONPALPABLE SOFT-TISSUE SARCOMAS
Gabriela San Martin
Favorite
Sanchez-Fdez, Adrian

Dept. of Surgery, Moores Cancer Center, University of California San Diego
(P 197) DIFFERENTIAL EFFECTS OF ANAGRELIDE IN GASTROINTESTINAL STROMAL TUMORS (GIST) IN VITRO
Adrian Sanchez-Fdez
Favorite
SANCHO MARQUEZ, MARIA DEL PILAR

HOSPITAL VIRGEN DEL ROCÍO
(P 321) COMPARATIVE ANALYSIS OF FIRST-LINE DOXORUBICIN-BASED COMBINATION REGIMENS IN METASTATIC LEIOMYOSARCOMA: IMPACT ON SURVIVAL AND DISEASE CONTROL
MARIA DEL PILAR SANCHO MARQUEZ
Favorite
Sancho-Márquez, Pilar

Hospital Universitario Virgen del Rocio
(P 115) SINGLE-CENTER EXPERIENCE WITH TYROSIN KINASA INHIBITORS IN ADVANCED BONE SARCOMA: EFFICACY AND SAFETY OUTCOMES
Pilar Sancho-Márquez
Favorite
Sandroni, Giulia

Humanitas University
(P 365) UROLOGICAL RECONSTRUCTION DURING RETROPERITONEAL AND PELVIC SARCOMA SURGERY: EXPERIENCE FROM A HIGH-VOLUME SARCOMA CENTER
Giulia Sandroni
Favorite
Sandrucci, Sergio

University of Turin
(P 328) INNOVATING SARCOMA EDUCATION: EARLY OUTCOMES OF THE ITALIAN SOCIETY OF SURGICAL ONCOLOGY (SICO) SARCOMA SOCIAL MULTI-PLATFORM JOURNAL CLUB INITIATIVE
Sergio Sandrucci
Favorite
Sanfilippo, Roberta

Fondazione IRCCS Istituto nazionale dei tumori
(P 308) IMPACT OF PSOAS MUSCLE RESECTION ON OUTCOMES IN PRIMARY RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMA
Roberta Sanfilippo
Favorite
(P 331) MAINTENANCE THERAPY (M-TP) WITH DACARBAZINE (DTIC) AFTER FIRST-LINE ANTHRACYCLINE-BASED DOUBLET IN ADVANCED LEIOMYOSARCOMA (LMS) PATIENTS (PTS): OUTCOMES OF A CASE SERIES IN A SINGLE REFERRAL CENTER
Roberta Sanfilippo
Favorite
(P 452) EFFECTIVENESS OF ERIBULIN FOR MYXOID PLEOMORPHIC LIPOSARCOMA: INSIGHTS FROM A PATIENT-DERIVED MODEL AND CLINICAL TRANSLATION IN A PATIENT WITH ADVANCED DISEASE
Roberta Sanfilippo
Favorite
Sangalli, Claudia

Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan
(P 277) THE ROLE OF RADIOTHERAPY IN THE MULTIDISCIPLINARY MANAGEMENT OF RADIATION-ASSOCIATED ANGIOSARCOMA OF THE BREAST: A REFERRAL CENTER EXPERIENCE
Claudia Sangalli
Favorite
(P 308) IMPACT OF PSOAS MUSCLE RESECTION ON OUTCOMES IN PRIMARY RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMA
Claudia Sangalli
Favorite
(P 458) BETWEEN LYMPHOMAS AND SARCOMAS: A RETROSPECTIVE, MULTI-INSTITUTIONAL STUDY FROM THE ITALIAN SARCOMA GROUP (ISG) ON HISTIOCYTIC AND DENDRITIC CELL NEOPLASMS (HDCN)
Claudia Sangalli
Favorite
Saniei, Sami

Mayo Clinic, Rochester
(P 166) LARGE LANGUAGE MODEL EXTRACTION OF STRUCTURED DATA IN UNSTRUCTURED SARCOMA PATHOLOGY NOTES: A PILOT STUDY
Sami Saniei
Favorite
(P 167) LARGE LANGUAGE MODEL EXTRACTION OF STRUCTURED DATA FROM UNSTRUCTURED RADIATION ONCOLOGY NOTES: A PILOT STUDY
Sami Saniei
Favorite
Sankar, Neil

Strand Therapeutics Inc.
(P 433) PHASE I DOSE ESCALATION TRIAL OF STX-001, AN LNP SELF-REPLICATING MRNA EXPRESSING IL-12, IN PATIENTS WITH REFRACTORY TUMORS INCLUDING SARCOMAS
Neil Sankar
Favorite
Sankhala, Esha

Precision NextGen Oncology and Research Center
(P 230) CIRCULATING TUMOR DNA AS AN EARLY INDICATOR OF RESPONSE, PROGRESSION, AND RECURRENCE OF SARCOMAS
Esha Sankhala
Favorite
Sankhala, Esha

Precision NextGen Oncology
(P 433) PHASE I DOSE ESCALATION TRIAL OF STX-001, AN LNP SELF-REPLICATING MRNA EXPRESSING IL-12, IN PATIENTS WITH REFRACTORY TUMORS INCLUDING SARCOMAS
Esha Sankhala
Favorite
(P 440) CASE REPORT: COMPLETE CLINICAL AND MOLECULAR RESPONSE TO INTRATUMORAL STX-001, AN LNP-SELF REPLICATING MRNA EXPRESSING IL-12 IN A PATIENT WITH REFRACTORY ANGIOSARCOMA
Esha Sankhala
Favorite
Sankhala, Esha

Precision NextGen Oncology & Research Center
(P 471) COMBINATION CHEMOTHERAPY WITH GEMCITABINE AND PACLITAXEL: A HIGHLY EFFICACIOUS AND BETTER TOLERATED OPTION FOR ANGIOSARCOMA
Esha Sankhala
Favorite
Sankhala, Kamlesh

Precision NextGen Oncology and Research Center
(P 230) CIRCULATING TUMOR DNA AS AN EARLY INDICATOR OF RESPONSE, PROGRESSION, AND RECURRENCE OF SARCOMAS
Kamlesh Sankhala
Favorite
(P 407) PIMICOTINIB IN TENOSYNOVIAL GIANT CELL TUMOR (TGCT): LONG-TERM EFFICACY, SAFETY, AND PATIENT-REPORTED OUTCOMES FROM THE PHASE 3 MANEUVER STUDY
Kamlesh Sankhala
Favorite
(P 431) INVOKE: A PHASE 1 STUDY OF OKN4395, A FIRST-IN-CLASS EP2/EP4/DP1 TRIPLE PROSTANOID RECEPTOR ANTAGONIST, IN PATIENTS WITH ADVANCED SOLID TUMORS, INCLUDING SARCOMAS
Kamlesh Sankhala
Favorite
(P 433) PHASE I DOSE ESCALATION TRIAL OF STX-001, AN LNP SELF-REPLICATING MRNA EXPRESSING IL-12, IN PATIENTS WITH REFRACTORY TUMORS INCLUDING SARCOMAS
Kamlesh Sankhala
Favorite
Sankhala, Kamlesh

Precision NextGen Oncology
(P 440) CASE REPORT: COMPLETE CLINICAL AND MOLECULAR RESPONSE TO INTRATUMORAL STX-001, AN LNP-SELF REPLICATING MRNA EXPRESSING IL-12 IN A PATIENT WITH REFRACTORY ANGIOSARCOMA
Kamlesh Sankhala
Favorite
Sankhala, Kamlesh

Precision NextGen Oncology and Research Center
(P 471) COMBINATION CHEMOTHERAPY WITH GEMCITABINE AND PACLITAXEL: A HIGHLY EFFICACIOUS AND BETTER TOLERATED OPTION FOR ANGIOSARCOMA
Kamlesh Sankhala
Favorite
Sanz Beltrán, Judit

Hospital de la Santa Creu i Sant Pau
(P 385) PROGNOSTIC IMPACT OF PERIPHERAL BLOOD CELL RATIO VALUES IN PATIENTS WITH ADVANCED LEIOMYOSARCOMA: A REFERENCE CENTER EXPERIENCE.
Judit Sanz Beltrán
Favorite
Sanz, Vanesa

the healthcare business of Merck KGaA, Darmstadt, Germany
(P 434) A FIRST-IN-HUMAN PHASE 1, MULTICENTER, OPEN-LABEL STUDY OF M3554, A NOVEL ANTI-GD2 ANTIBODY-DRUG CONJUGATE, IN PATIENTS WITH ADVANCED SOLID TUMORS
Vanesa Sanz
Favorite
Saraee, Mo

Salford University
(P 392) CLASSIFICATION AND DIFFERENTIATIONOF MYXOID LIPOSARCOMA AND MYXOMA WITH MACHINE LEARNING
Mo Saraee
Favorite
(P 392) DIFFERENTIATION OF MYXOMA AND MYXOID LIPOSARCOMA BASED ON RADIOMICS PHENOTYPES
Mo Saraee
Favorite
Sarmento, Frederico

Instituto Português de Oncologia de Lisboa Francisco Gentil
(P 372) CLINICOPATHOLOGICAL FEATURES AND OUTCOMES OF PATIENTS WITH KAPOSI SARCOMA: A SINGLE CENTER RETROSPECTIVE REAL WORLD ANALYSIS
Frederico Sarmento
Favorite
Sarno, Shirley

University of California San Diego
(P 179) NEOADJUVANT AVAPRITINIB IN PDGFRA-MUTANT GIST: NEAR COMPLETE PATHOLOGICAL RESPONSES AT THE COST OF HIGH ADVERSE EVENT RATES
Shirley Sarno
Favorite
(P 180) COMPARATIVE EFFICACY OF GENERIC AND BRAND-NAME IMATINIB IN NEOADJUVANT TREATMENT OF KIT EXON 11 MUTANT GIST
Shirley Sarno
Favorite
Sarre-Lazcano, Catherine

Department of Surgery, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
(P 306) PROGNOSTIC NUTRITIONAL INDEX PREDICTS MAJOR POSTOPERATIVE COMPLICATIONS IN RETROPERITONEAL SARCOMA: RESULTS FROM THE LATAMSARC COHORT
Catherine Sarre-Lazcano
Favorite
Sarthy, Jay

Seattle Children's Research Institute
(P 260) MECHANISM AND EFFICACY OF ANTHRACYCLINE MEDIATED EPIGENETIC DISRUPTION IN BONE SARCOMAS.
Jay Sarthy
Favorite
Satake, Ryo

Shizuoka Cancer Center
(P 291) INTRA-ARTERIAL CHEMOTHERAPY WITH CONCOMITANT RADIATION THERAPY FOR UNRESECTABLE SARCOMA
Ryo Satake
Favorite
Satake, Tomoyuki

National Cancer Center Hospital East
(P 159) CHONDROSARCOMA IN JAPAN: A POPULATION-BASED ANALYSIS USING NATIONAL CANCER REGISTRY
Tomoyuki Satake
Favorite
Saunders, Amanda

Deciphera Pharmaceuticals, LLC
(P 422) EFFICACY WITH VIMSELTINIB IN PATIENTS (PTS) WITH TENOSYNOVIAL GIANT CELL TUMOR (TGCT) AND PRIOR COLONY-STIMULATING FACTOR 1 (CSF1) INHIBITOR THERAPY: A PHASE 2 CASE SERIES
Amanda Saunders
Favorite
Sayles, Leanne

UCSF
(P 08) BUILDING A MEDICAL DONATION NETWORK TO ENHANCE DEVELOPMENT OF PEDIATRIC TUMOR MODELS
Leanne Sayles
Favorite
Sayour, Elias

University of Florida
(P 248) AN EX VIVO ASSAY TO PREDICT IMMUNOTHERAPY RESPONSE IN SARCOMA
Elias Sayour
Favorite
(P 426) A PHASE I/II TRIAL USING RNA LIPID NANOPARTICLES FOR RECURRENT OSTEOSARCOMA: A REPORT FROM THE NATIONAL PEDIATRIC CANCER FOUNDATION
Elias Sayour
Favorite
Sbanchi, Giulia

IRCCS Rizzoli Orthopaedic Institute
(P 18) ESTABLISHMENT AND CHARACTERIZATION OF A NOVEL PRIMARY CELL LINE FROM A BONE METASTASIS OF OSTEOSARCOMA
Giulia Sbanchi
Favorite
Sbaraglia, Marta

University of Padua, Padua, Italy
(P 231) INCREASED LIFETIME RISK (LTR) OF SOFT TISSUE SARCOMAS (STS) IN PATIENTS WITH LOW-RISK GASTROINTESTINAL STROMAL TUMORS (GIST): A RETROSPECTIVE ANALYSIS FROM THE ITALIAN SARCOMA GROUP (ISG)
Marta Sbaraglia
Favorite
Sbaraglia, Marta

Azianda Ospedaliera di Padova
(P 458) BETWEEN LYMPHOMAS AND SARCOMAS: A RETROSPECTIVE, MULTI-INSTITUTIONAL STUDY FROM THE ITALIAN SARCOMA GROUP (ISG) ON HISTIOCYTIC AND DENDRITIC CELL NEOPLASMS (HDCN)
Marta Sbaraglia
Favorite
Scally, Christopher

MD Anderson Cancer Center
(P 351) THE ROLE OF SOCIOECONOMIC DISPARITIES ON SURVIVAL OUTCOMES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Christopher Scally
Favorite
Scarborough, Mark T.

University of Florida
(P 129) HIJACKED FUEL: GLYCOGEN-DRIVEN METABOLIC SHIFTS IN IDH1-MUTANT CHONDROSARCOMA
Mark T. Scarborough
Favorite
Schöffski, Patrick

General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute
(P 33) THE NOVEL TRANSCRIPTIONAL INHIBITORS ECUBECTEDIN AND PM54 DEMONSTRATE ANTITUMOR ACTIVITY IN PATIENT-DERIVED XENOGRAFT MODELS OF SOFT TISSUE SARCOMA
Patrick Schöffski
Favorite
(P 69) EPIDEMIOLOGY AND POTENTIAL CLINICAL RELEVANCE OF TOP1 AND TOP2A TOPOISOMERASES EXPRESSION IN SOFT TISSUE SARCOMA
Patrick Schöffski
Favorite
(P 70) EPIDEMIOLOGY AND POTENTIAL CLINICAL RELEVANCE OF CONTACTIN-4 EXPRESSION IN SOFT TISSUE SARCOMA
Patrick Schöffski
Favorite
(P 194) UPDATED RESULTS FROM STRATEGIST 1: A PHASE 1/1B STUDY OF IDRX-42 (GSK6042981A) IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST)
Patrick Schöffski
Favorite
(P 416) A PHASE 2 MULTICENTER OPEN-LABEL BASKET STUDY OF TAZEMETOSTAT IN ADULT PATIENTS WITH INI1-NEGATIVE EPITHELIOID SARCOMA – FINAL ANALYSIS
Patrick Schöffski
Favorite
(P 434) A FIRST-IN-HUMAN PHASE 1, MULTICENTER, OPEN-LABEL STUDY OF M3554, A NOVEL ANTI-GD2 ANTIBODY-DRUG CONJUGATE, IN PATIENTS WITH ADVANCED SOLID TUMORS
Patrick Schöffski
Favorite
Schüller, Ulrich

University Medical Center Hamburg-Eppendorf, Hamburg, Germany
(P 64) ATRX EXPRESSION CORRELATES WITH REDUCED IMMUNE CHECKPOINT EXPRESSION AND POOR SURVIVAL IN HIGH-RISK SOFT TISSUE SARCOMAS
Ulrich Schüller
Favorite
Scharpf, Katrin R.

Psycho-oncology service in cooperation with the Central Institute for Mental Health Mannheim, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University
(P 441) COLOSARC-Q: A PROSPECTIVE MULTICENTER STUDY FOR EVALUATING SURGICAL STRATEGIES FOR COLORECTAL RESECTIONS AND POSTOPERATIVE QUALITY OF LIFE IN RETROPERITONEAL SARCOMA PATIENTS
Katrin R. Scharpf
Favorite
Scharschmidt, Thomas

The Ohio State University
(P 161) CLINICAL CHARACTERISTICS, PATTERNS OF CARE, AND TREATMENT OUTCOMES OF CHONDROSARCOMA: A SINGLE-INSTITUTIONAL EXPERIENCE
Thomas Scharschmidt
Favorite
Schaub, Stephanie

Fred Hutchinson Cancer Center
(P 287) A PHASE 1 STUDY OF NEOADJUVANT CABOZANTINIB IN COMBINATION WITH RADIATION THERAPY FOR SARCOMAS OF THE EXTREMITIES
Stephanie Schaub
Favorite
Scheid, Meghan

University of Colorado School of Medicine
(P 234) DOXORUBICIN PLUS BOTENSILIMAB, A NEXT GENERATION CTLA4 INHIBITOR, WITH OR WITHOUT BALSTILIMAB, A PD1 INHIBITOR, IN PATIENTS WITH ADVANCED SOFT TISSUE SARCOMAS
Meghan Scheid
Favorite
Scheidt, Matthew

MCW
(P 111) DOES DOSE MATTER? POSTOPERATIVE RADIATION DOSE AND OUTCOMES FOLLOWING FIXATION OF METASTATIC EXTREMITY BONE LESIONS
Matthew Scheidt
Favorite
Scheuplein, Nicolas

Cancer Information Service, German Cancer Research Center (DKFZ)
(P 455) DEVELOPMENT OF PATIENT-CENTERED INFORMATION MATERIAL ON RADIATION-INDUCED SARCOMA: QUALITATIVE RESULTS FROM FOCUS GROUPS OF THE TETRIS-PROJECT
Nicolas Scheuplein
Favorite
Schieffer, Kathleen

Steve and Cindy Rasmussen Institute for Genomic Medicine, The Abigail Wexner Research Institute, Nationwide Children’s Hospital
(P 264) RARE CASE OF INFLAMMATORY MYOFIBROBLASTIC TUMOR (IMT) IN NEWBORN
Kathleen Schieffer
Favorite
(P 377) GERMLINE RECQL4 VARIANT IN A PEDIATRIC PATIENT WITH EWING SARCOMA AND DESMOID FIBROMATOSIS
Kathleen Schieffer
Favorite
Schilling, Freimut

Luzerner Kantonsspital (LUKS)
(P 419) PROSPECTIVE REAL-WORLD STUDY OF LAROTRECTINIB (LARO) IN PATIENTS (PTS) WITH TRK FUSION SOLID TUMORS: INTERIM ANALYSIS OF ON-TRK
Freimut Schilling
Favorite
Schloss, Jennifer

Memorial Sloan Kettering Cancer Center
(P 265) MULTI-SITE SINGLE CELL TRANSCRIPTOMICS REVEAL DISTINCT IMMUNE INFILTRATIVE PATTERNS IN DESMOPLASTIC SMALL ROUND CELL TUMOR
Jennifer Schloss
Favorite
Schmitt, Saskia

Tubulis
(P 34) EXPRESSION OF ONCOFETAL ANTIGEN 5T4 IN SARCOMA SUBTYPES AND PRECLINICAL ACTIVITY OF TUB-030, A NOVEL 5T4-TARGETING ANTIBODY-DRUG CONJUGATE (ADC)
Saskia Schmitt
Favorite
Schmitz, Erika

University of British Columbia
(P 196) SURVEILLANCE STRATEGIES AND LONG-TERM OUTCOMES IN LOW-RISK GASTRIC GASTROINTESTINAL STROMAL TUMORS (GGISTS)
Erika Schmitz
Favorite
Schmitz, Marc

Institute of Immunology, Faculty of Medicine Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany,National Center for Tumor Diseases (NCT), Dresden, Germany, German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany
(P 243) CLINICAL SIGNIFICANCE OF TUMOR-INFILTRATING IMMUNE CELL SUBSETS IN THE RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMAS AND LEIOMYOSARCOMAS
Marc Schmitz
Favorite
Schoedel, Karen

University of Pittsburgh School of Medicine
(P 65) INVESTIGATING MACROPHAGE POPULATIONS IN PRIMARY AND METASTATIC SARCOMA SAMPLES
Karen Schoedel
Favorite
Scholte, Claire

LUMC
(P 127) AN INTEGRATED CLINICAL GENOMIC AND TRANSCRIPTOMIC SUBGROUPING OF CENTRAL CHONDROSARCOMA
Claire Scholte
Favorite
(P 144) THE RISK OF PATHOLOGICAL FRACTURES AFTER INTRALESIONAL CURETTAGE IN ATYPICAL CARTILAGINOUS TUMOURS: A RETROSPECTIVE COHORT STUDY
Claire Scholte
Favorite
Schuebbe, Gesa

Department of Medicine III, LMU University Hospital, Munich, Germany
(P 437) CLINICAL DATA CONFIRM GALENIC PRINCIPLE AND DEMONSTRATE THERAPEUTIC POTENTIAL OF THE001 (DPPG2-TSL-DOX) PLUS REGIONAL HYPERTHERMIA IN SOFT TISSUE SARCOMA
Gesa Schuebbe
Favorite
Schuetze, Scott

University of Michigan
(P 227) TREATMENT PATTERNS IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMORS: ADDRESSING COMMUNICATION IN A NEW THERAPEUTIC LANDSCAPE
Scott Schuetze
Favorite
Schuldt, Samantha

Northwestern University Feinberg School of Medicine
(P 429) SINGLE-ARM, OPEN-LABEL PHASE II TRIAL OF XL092 (ZANZALINTINIB) IN PATIENTS WITH ADVANCED LEIOMYOSARCOMA: TRIAL IN PROGRESS
Samantha Schuldt
Favorite
Schulte, Brian

UCSF Helen Diller Comprehensive Cancer Center
(P 439) AN OPEN LABEL MULTICENTER PHASE 2 STUDY WITH SAFETY LEAD IN OF INTRATUMORAL VUSOLIMOGENE ODERPAREPVEC IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ANGIOSARCOMA
Brian Schulte
Favorite
Schuster, Kathrin

Sarcoma Patient Advocacy Global Network e.V./Assoc.
(P 229) DETERMINANTS OF DIAGNOSTIC INTERVAL IN EPITHELIOID HEMANGIOENDOTHELIOMA: A LINEAR AND QUANTILE REGRESSION ANALYSIS OF PATIENT-REPORTED DATA FROM THE SPAGN GLOBAL SARCOMA DIAGNOSIS PATHWAY SURVEY
Kathrin Schuster
Favorite
Schutz, John

University of Colorado Department of Orthopedics
(P 268) QUALITY OF LIFE OUTCOMES IN PEDIATRIC PATIENTS UNDERGOING SURGICAL INTERVENTION FOR LOWER EXTREMITY BONE SARCOMAS
John Schutz
Favorite
Schwartzbaum, Daniel

Jackson Memorial Hospital/University of Miami Health System
(P 254) EOSINOPHILIC FASCIITIS (EF) AS A COMPLICATION OF NATURAL KILLER (NK) CELL-BASED IMMUNOTHERAPY IN A YOUNG ADULT WITH RECURRENT METASTATIC EWING SARCOMA
Daniel Schwartzbaum
Favorite
Schwartz, Gary

Cleveland Clinic
(P 284) THE IMPACT OF SARCOMA SBRT ON THE IMMUNE SYSTEM: EARLY RESULTS FROM A PROSPECTIVE TRIAL
Gary Schwartz
Favorite
Schwartz, Gary

Case Comprehensive Cancer Center
(P 430) A PH/2 STUDY OF THE RADIOPHARMACEUTICAL [AC-225]RTX-2358 IN THE TREATMENT OF RELAPSED / REFRACTORY (R/R) SOFT TISSUE SARCOMA (STS) THE ATLAS STUDY - ACTINIUM THERAPY FOR LATE-STAGE AGGRESSIVE SARCOMAS
Gary Schwartz
Favorite
Schwartz, Herbert

Vanderbilt University Medical Center
(P 84) A MULTICENTER COMPARISON OF REVERSE TOTAL SHOULDER ARTHROPLASTY VERSUS HEMIARTHROPLASTY FOR ENDOPROSTHETIC RECONSTRUCTION FOLLOWING ONCOLOGIC RESECTION OF THE PROXIMAL HUMERUS
Herbert Schwartz
Favorite
(P 85) MAKING NEGATIVE MARGIN MUSCULOSKELETAL TUMOR SURGERY A VIRTUAL REALITY USING 3D SPECIMEN SCANNING
Herbert Schwartz
Favorite
(P 97) RISK FACTORS ASSOCIATED WITH AMPUTATION VERSUS CONTINUED LIMB SALVAGE IN LOWER EXTREMITY ENDOPROSTHETIC RECONSTRUCTION
Herbert Schwartz
Favorite
Schwenke, Kay

Department of Vascular Surgery, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University
(P 303) MULTIVISCERAL RESECTIONS AND URINARY TRACT RECONSTRUCTION TECHNIQUES IN THE SURGERY OF RETROPERITONEAL SARCOMAS: A CASE SERIES.
Kay Schwenke
Favorite
Sciandra, Marika

IRCCS Rizzoli Orthopaedic Institute
(P 18) ESTABLISHMENT AND CHARACTERIZATION OF A NOVEL PRIMARY CELL LINE FROM A BONE METASTASIS OF OSTEOSARCOMA
Marika Sciandra
Favorite
Sciot, Raf

KU Leuven
(P 70) EPIDEMIOLOGY AND POTENTIAL CLINICAL RELEVANCE OF CONTACTIN-4 EXPRESSION IN SOFT TISSUE SARCOMA
Raf Sciot
Favorite
Scott, Jacob

Cleveland Clinic
(P 10) COLLATERAL SENSITIVIES EMERGE DURING THE EVOLUTION OF CHEMORESISTANCE TO MAP CHEMOTHERAPY IN OSTEOSARCOMA
Jacob Scott
Favorite
(P 284) THE IMPACT OF SARCOMA SBRT ON THE IMMUNE SYSTEM: EARLY RESULTS FROM A PROSPECTIVE TRIAL
Jacob Scott
Favorite
Scott, Susan

SpringWorks Therapeutics
(P 364) TRENDS IN SURGICAL MANAGEMENT OF DESMOID TUMOR IN THE VETERANS AFFAIRS (VA) NATIONAL DATABASE
Susan Scott
Favorite
Sebio García, Ana

Hospital de la Santa Creu i Sant Pau, IR Sant Pau
(P 71) GERMLINE POLYMORPHISMS IN THE VEGF PATHWAY AS PROGNOSTIC BIOMARKERS IN LOCALIZED HIGH-GRADE OSTEOSARCOMA: A STUDY BASED ON DATA FROM THE GEIS-33 PROTOCOL
Ana Sebio García
Favorite
(P 218) THE IMPACT OF BROADENED GENETIC COUNSELLING REFERRAL CRITERIA IN SARCOMA PATIENTS: A REFERENCE CENTRE'S EXPERIENCE
Ana Sebio García
Favorite
(P 383) MULTIDISCIPLINARY TREATMENT OF INGUINOSCROTAL SARCOMAS: ANALYSIS OF 39 CASES TREATED BY SURGICAL APPROACH
Ana Sebio García
Favorite
(P 385) PROGNOSTIC IMPACT OF PERIPHERAL BLOOD CELL RATIO VALUES IN PATIENTS WITH ADVANCED LEIOMYOSARCOMA: A REFERENCE CENTER EXPERIENCE.
Ana Sebio García
Favorite
(P 389) UNRESECTABLE AND METASTATIC DEDIFFERENTIATED LIPOSARCOMA (DDLPS): INSIGHTS FROM A MULTICENTER REAL-WORLD COHORT (RWC)
Ana Sebio García
Favorite
Seddon, Beatrice

University College London Hospitals
(P 281) LOCAL CONTROL WITH MODERATELY HYPOFRACTIONATED DEFINITIVE RADIOTHERAPY DELIVERED WITH A SIMULTANEOUS INTEGRATED BOOST TECHNIQUE TO NON-EXTREMITY SOFT TISSUE AND BONE SARCOMAS
Beatrice Seddon
Favorite
Segers, Blair

Children's Hospital of Philadelphia
(P 262) EVALUATING FRONT-LINE THERAPY ACCORDANCE WITH CURRENT SYNOVIAL SARCOMA GUIDELINES
Blair Segers
Favorite
(P 263) DESCRIBING THE CHARACTERISTICS AND TREATMENT OF SYNOVIAL SARCOMA IN THE RECURRENT SETTING
Blair Segers
Favorite
Seier, Kenneth

Memorial Sloan Kettering Cancer Center
(P 409) RETROSPECTIVE ANALYSIS OF PROGNOSTIC FACTORS INCLUDING HLA GENOTYPE IN MYXOID LIPOSARCOMA
Kenneth Seier
Favorite
Seitz, Guido

University Hospital Giessen-Marburg
(P 250) OUTCOME OF INFANTS WITH RHABDOMYOSARCOMA: A REPORT FROM THE INTERNATIONAL SOFT TISSUE SARCOMA CONSORTIUM
Guido Seitz
Favorite
Selby, Luke

University of Kansas Medical Center
(P 366) WOUND COMPLICATIONS AFTER ULTRA-HYPOFRACTIONATED NEOADJUVANT RADIATION FOR SOFT TISSUE SARCOMA: WHAT IS OPTIMAL SURGICAL TIMING?
Luke Selby
Favorite
Seliga, Katarzyna

Cancer Molecular and Genetic Diagnostics Laboratory, Maria Sklodowska-Curie National Research Institute of Oncology
(P 27) MOLECULAR CHARACTERIZATION OF RESPONSE TO NEOADJUVANT CHEMORADIATION IN PATIENTS WITH LOCALLY ADVANCED SOFT TISSUE SARCOMAS
Katarzyna Seliga
Favorite
Seligson, Nathan

University of Florida
(P 275) NEXT GENERATION SEQUENCING IN ADOLESCENT AND YOUNG ADULT (AYA) SARCOMAS: CLINICAL IMPACT, DIAGNOSTIC UTILITY, AND IMPLICATIONS
Nathan Seligson
Favorite
Selmek, Aubrie

Ohio State University
(P 19) SERUM EXOSOMES IDENTIFY AN ABERRANT PROTEOMIC SIGNATURE IN CANINE OSTEOSARCOMA PRECEDING METASTATIC PROGRESSION
Aubrie Selmek
Favorite
Selmic, Laura

Ohio State University
(P 259) PRECLINICAL MODELING OF CHEMOTHERAPY RELEASE IDENTIFIES MITOCHONDRIAL ADAPTATIONS IN DOXORUBICIN TREATED OSTEOSARCOMA
Laura Selmic
Favorite
Semrau, Sabine

Department of Radiation Oncology, Universitätsstraße 27, 91054 Erlangen, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Germany
(P 288) IDENTIFICATION OF A DNA REPAIR INHIBITOR FOR THE COMBINATION WITH LURBINECTEDIN AND RADIOTHERAPY IN SARCOMA CELL LINES
Sabine Semrau
Favorite
Sen, Jasmine

Deciphera Pharmaceuticals, LLC
(P 422) EFFICACY WITH VIMSELTINIB IN PATIENTS (PTS) WITH TENOSYNOVIAL GIANT CELL TUMOR (TGCT) AND PRIOR COLONY-STIMULATING FACTOR 1 (CSF1) INHIBITOR THERAPY: A PHASE 2 CASE SERIES
Jasmine Sen
Favorite
Serra, Massimo

IRCCS Rizzoli Orthopaedic Institute
(P 18) ESTABLISHMENT AND CHARACTERIZATION OF A NOVEL PRIMARY CELL LINE FROM A BONE METASTASIS OF OSTEOSARCOMA
Massimo Serra
Favorite
(P 71) GERMLINE POLYMORPHISMS IN THE VEGF PATHWAY AS PROGNOSTIC BIOMARKERS IN LOCALIZED HIGH-GRADE OSTEOSARCOMA: A STUDY BASED ON DATA FROM THE GEIS-33 PROTOCOL
Massimo Serra
Favorite
Serrano, César

Sarcoma Translational Research Program, Hospital Universitari Vall d'Hebron – Vall d'Hebron Institut d'Oncologia
(P 194) UPDATED RESULTS FROM STRATEGIST 1: A PHASE 1/1B STUDY OF IDRX-42 (GSK6042981A) IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST)
César Serrano
Favorite
(P 389) UNRESECTABLE AND METASTATIC DEDIFFERENTIATED LIPOSARCOMA (DDLPS): INSIGHTS FROM A MULTICENTER REAL-WORLD COHORT (RWC)
César Serrano
Favorite
(P 407) PIMICOTINIB IN TENOSYNOVIAL GIANT CELL TUMOR (TGCT): LONG-TERM EFFICACY, SAFETY, AND PATIENT-REPORTED OUTCOMES FROM THE PHASE 3 MANEUVER STUDY
César Serrano
Favorite
seshadri, namratha

Tata Memorial Hospital
(P 379) IMPACT OF EWSR1 GENE REARRANGEMENT TESTING ON DIAGNOSIS OF A WIDE RANGE OF SOLID TUMOURS
namratha seshadri
Favorite
Sesser, Andrew

University of Miami, Department of Radiation Oncology
(P 289) SIX YEAR FOLLOW-UP ON CIVASHEET® USE FOR SOFT TISSUE SARCOMA: A SINGLE INSTITUTION EXPERIENCE
Andrew Sesser
Favorite
Seto, Andrew

University Health Network
(P 323) EVALUATION OF COSMIC MUTATIONAL SIGNATURES IN SOFT TISSUE SARCOMA
Andrew Seto
Favorite
Setty, Bhuvana

Nationwide Children's Hospital
(P 254) EOSINOPHILIC FASCIITIS (EF) AS A COMPLICATION OF NATURAL KILLER (NK) CELL-BASED IMMUNOTHERAPY IN A YOUNG ADULT WITH RECURRENT METASTATIC EWING SARCOMA
Bhuvana Setty
Favorite
(P 264) RARE CASE OF INFLAMMATORY MYOFIBROBLASTIC TUMOR (IMT) IN NEWBORN
Bhuvana Setty
Favorite
(P 377) GERMLINE RECQL4 VARIANT IN A PEDIATRIC PATIENT WITH EWING SARCOMA AND DESMOID FIBROMATOSIS
Bhuvana Setty
Favorite
Severe, Nicolas

Pyxis Oncology
(P 29) ANTI-TUMOR ACTIVITY OF MICVOTABART PELIDOTIN IS ASSOCIATED WITH ENZYME GENE EXPRESSION IN PATIENT-DERIVED XENOGRAFT SARCOMA MODELS
Nicolas Severe
Favorite
Sevilla-Garcia, Isabel

Hospital Universitario Virgen de la Victoria, Clinical and Translational Cancer Research/Malaga Biomedical Research Institute (IBIMA) Málaga
(P 389) UNRESECTABLE AND METASTATIC DEDIFFERENTIATED LIPOSARCOMA (DDLPS): INSIGHTS FROM A MULTICENTER REAL-WORLD COHORT (RWC)
Isabel Sevilla-Garcia
Favorite
Seward, David

University of Vermont, Dept of Pathology and Laboratory Medicine
(P 24) THE SIRTUIN SIRT5 SUPPORTS EWING SARCOMA SURVIVAL VIA REGULATION OF EWS-FLI1 STABILITY AND ACTIVITY
David Seward
Favorite
Sexton, Sarah

Dana-Farber Cancer Institute
(P 427) PHASE 1/2 TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF PEEL-224 IN COMBINATION WITH VINCRISTINE AND TEMOZOLOMIDE IN ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY SARCOMAS
Sarah Sexton
Favorite
Shafer, Amanda

University of Michigan
(P 50) A NEW MURINE MODEL OF DEDIFFERENTIATED LIPOSARCOMA DEFINED BY HIGH PROLIFERATION AND METABOLIC ADAPTABILITY
Amanda Shafer
Favorite
(P 52) VALIDATION OF SYNGENEIC MURINE DEDIFFERENTIATED LIPOSARCOMA MODELS FOR PRECLINICAL EVALUATION OF THERAPEUTIC SENSITIVITY
Amanda Shafer
Favorite
Shafi, Saba

The Ohio State University Wexner Medical Center
(P 153) DOES THE QUANTITY OF DEDIFFERENTIATION MATTER IN THE CLINICAL OUTCOMES OF DEDIFFERENTIATED CHONDROSARCOMA? A 10-YEAR SINGLE TERTIARY INSTITUTIONAL EXPERIENCE OF A SERIES.
Saba Shafi
Favorite
Shah, Karan

The University of Sheffield
(P 136) ESTROGEN HAS A PROTECTIVE EFFECT ON CHONDROSARCOMA GROWTH IN VITRO AND IN VIVO
Karan Shah
Favorite
Shah, Pooja

MD Anderson Cancer Center
(P 184) MTAP IN GASTROINTESTINAL STROMAL TUMOR (GIST): RATE OF MTAP LOSS AND CONCORDANCE BETWEEN GENOMIC SEQUENCING AND IMMUNOHISTOCHEMISTRY
Pooja Shah
Favorite
Shahzad, Hania

UC Davis Health
(P 349) THE COST OF SURVEILLANCE IN CALIFORNIA: MRI UTILIZATION IN RECURRENT EXTREMITY SOFT TISSUE SARCOMA
Hania Shahzad
Favorite
Shamim, Shamim

All India Institute of Medical Sciences, New Delhi
(P 276) RADIATION-INDUCED SARCOMA (RIS): CLINICAL SPECTRUM AND ONCOLOGIC OUTCOMES FROM A TERTIARY INDIAN SARCOMA CLINIC
Shamim Shamim
Favorite
Shamsutdinova, Diana

MD Anderson Cancer Center
(P 47) EWSR1::WT1 FUSION ONCOPROTEIN ACTIVITY SHAPES LINEAGE HETEROGENEITY IN DESMOPLASTIC SMALL ROUND CELL TUMORS
Diana Shamsutdinova
Favorite
(P 184) MTAP IN GASTROINTESTINAL STROMAL TUMOR (GIST): RATE OF MTAP LOSS AND CONCORDANCE BETWEEN GENOMIC SEQUENCING AND IMMUNOHISTOCHEMISTRY
Diana Shamsutdinova
Favorite
(P 242) IMMUNE PROFILING OF UNDIFFERENTIATED PLEOMORPHIC SARCOMAS REVEALS DISTINCT PROGNOSTIC SUBGROUPS
Diana Shamsutdinova
Favorite
Shang, Lulu

The University of Texas MD Anderson Cancer Center
(P 172) COMPARISON OF CELL SEGMENTATION METHODS IN SOFT TISSUE SARCOMA (STS) SPATIAL PROTEOMIC DATASETS
Lulu Shang
Favorite
Shao, James

Biostatistics, IDRx
(P 194) UPDATED RESULTS FROM STRATEGIST 1: A PHASE 1/1B STUDY OF IDRX-42 (GSK6042981A) IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST)
James Shao
Favorite
Sharma, Maitreyi

Deciphera Pharmaceuticals, LLC
(P 358) EFFECT OF A HIGH-FAT MEAL ON THE PHARMACOKINETICS (PK) OF VIMSELTINIB, AN ORAL INHIBITOR OF THE COLONY-STIMULATING FACTOR 1 RECEPTOR (CSF1R), IN HEALTHY PARTICIPANTS
Maitreyi Sharma
Favorite
(P 376) EFFECT OF ITRACONAZOLE (ITZ) AND RABEPRAZOLE (RBP) ON THE PHARMACOKINETICS (PK) OF VIMSELTINIB, AN ORAL INHIBITOR OF THE COLONY-STIMULATING FACTOR 1 RECEPTOR, IN HEALTHY PARTICIPANTS
Maitreyi Sharma
Favorite
(P 422) EFFICACY WITH VIMSELTINIB IN PATIENTS (PTS) WITH TENOSYNOVIAL GIANT CELL TUMOR (TGCT) AND PRIOR COLONY-STIMULATING FACTOR 1 (CSF1) INHIBITOR THERAPY: A PHASE 2 CASE SERIES
Maitreyi Sharma
Favorite
Sharma, Nikita

University of Miami Miller School of Medicine
(P 201) METASTATIC PATTERNS, TREATMENT MODALITIES, AND OVERALL SURVIVAL IN OLIGOMETASTATIC GIST: A SINGLE-CENTER RETROSPECTIVE STUDY
Nikita Sharma
Favorite
Sharma, Sunil

Honor Health
(P 415) A PHASE 1/2 TRIAL OF FOG-001, A FIRST-IN-CLASS DIRECT β-CATENIN:TCF4 INHIBITOR: SAFETY AND PRELIMINARY ANTITUMOR ACTIVITY IN PATIENTS WITH DESMOID TUMORS (DT)
Sunil Sharma
Favorite
Sharp, Andrew

MGH
(P 392) CLASSIFICATION AND DIFFERENTIATIONOF MYXOID LIPOSARCOMA AND MYXOMA WITH MACHINE LEARNING
Andrew Sharp
Favorite
(P 392) DIFFERENTIATION OF MYXOMA AND MYXOID LIPOSARCOMA BASED ON RADIOMICS PHENOTYPES
Andrew Sharp
Favorite
Shaw, Matthew

Huntsman Cancer Institute
(P 01) FEASIBILITY OF A QUANTITATIVE METHYLATION-BASED CTDNA ASSAY IN PATIENTS WITH ADVANCED SARCOMAS
Matthew Shaw
Favorite
Shay, Bracha

Ohio State University
(P 19) SERUM EXOSOMES IDENTIFY AN ABERRANT PROTEOMIC SIGNATURE IN CANINE OSTEOSARCOMA PRECEDING METASTATIC PROGRESSION
Bracha Shay
Favorite
Sheel, Ankur

The Ohio State University
(P 170) GEMSARC: AN AI BASED PREDICTIVE GENE SIGNATURE FOR GEMCITABINE EFFICACY IN ADVANCED SOFT-TISSUE SARCOMAS
Ankur Sheel
Favorite
(P 408) REAL-WORLD SINGLE-CENTER INSIGHTS INTO CT-DNA DYNAMICS ACROSS SOFT TISSUE SARCOMAS
Ankur Sheel
Favorite
Shelmidine, Katherine

Emory University
(P 21) EXAMINING THE THERAPEUTIC EFFECT OF TBL1/ β-CATENIN TARGETED COMBINATION THERAPIES ON METASTATIC OSTEOSARCOMA
Katherine Shelmidine
Favorite
Shen, Chuan

Pyxis Oncology
(P 29) ANTI-TUMOR ACTIVITY OF MICVOTABART PELIDOTIN IS ASSOCIATED WITH ENZYME GENE EXPRESSION IN PATIENT-DERIVED XENOGRAFT SARCOMA MODELS
Chuan Shen
Favorite
Sheng, Michael

Department of Dermatology, University of California, Davis
(P 244) INTRATUMORAL TIGIT BLOCKADE AUGMENTS ANTI-TUMOR RESPONSES AND BYPASSES HYPERFUNCTIONALITY OF PERIPHERAL TIGIT+ NK CELLS IN MOUSE AND HUMAN MODELS OF BONE AND SOFT TISSUE SARCOMA
Michael Sheng
Favorite
Shen, Jingnan

Musculoskeletal Oncology, 1st Affiliated Hospital of Sun Yat-sen University
(P 407) PIMICOTINIB IN TENOSYNOVIAL GIANT CELL TUMOR (TGCT): LONG-TERM EFFICACY, SAFETY, AND PATIENT-REPORTED OUTCOMES FROM THE PHASE 3 MANEUVER STUDY
Jingnan Shen
Favorite
Shenoy, Devika

Duke University School of Medicine
(P 214) FINANCIAL TOXICITY IN PATIENTS WITH A HISTORY OF EXTREMITY AND PELVIC SARCOMA TREATMENT
Devika Shenoy
Favorite
Sheoran, Varun

All India Institute of Medical Sciences, New Delhi
(P 276) RADIATION-INDUCED SARCOMA (RIS): CLINICAL SPECTRUM AND ONCOLOGIC OUTCOMES FROM A TERTIARY INDIAN SARCOMA CLINIC
Varun Sheoran
Favorite
Shepard, Dale

Cleveland Clinic
(P 284) THE IMPACT OF SARCOMA SBRT ON THE IMMUNE SYSTEM: EARLY RESULTS FROM A PROSPECTIVE TRIAL
Dale Shepard
Favorite
Sheppard, Heather

St. Jude Children's Research Hospital
(P 241) MACROPHAGE INHIBITION ENHANCES PERIPHERAL CAR T CELL EXPANSION AND TUMOR CONTROL IN A PATIENT-DERIVED HUMANIZED MODEL OF AUTOLOGOUS CAR T CELL EFFICACY IN PEDIATRIC OSTEOSARCOMA (OS)
Heather Sheppard
Favorite
Sheridan, Aine

St Vincent's University Hospital
(P 211) HEALTH-RELATED QUALITY OF LIFE IN IRISH SARCOMA PATIENTS
Aine Sheridan
Favorite
(P 213) FINANCIAL TOXICITY IN IRISH SARCOMA CARE: A SINGLE-CENTRE ANALYSIS
Aine Sheridan
Favorite
Sherman, Matthew

Deciphera Pharmaceuticals, LLC
(P 358) EFFECT OF A HIGH-FAT MEAL ON THE PHARMACOKINETICS (PK) OF VIMSELTINIB, AN ORAL INHIBITOR OF THE COLONY-STIMULATING FACTOR 1 RECEPTOR (CSF1R), IN HEALTHY PARTICIPANTS
Matthew Sherman
Favorite
(P 376) EFFECT OF ITRACONAZOLE (ITZ) AND RABEPRAZOLE (RBP) ON THE PHARMACOKINETICS (PK) OF VIMSELTINIB, AN ORAL INHIBITOR OF THE COLONY-STIMULATING FACTOR 1 RECEPTOR, IN HEALTHY PARTICIPANTS
Matthew Sherman
Favorite
(P 422) EFFICACY WITH VIMSELTINIB IN PATIENTS (PTS) WITH TENOSYNOVIAL GIANT CELL TUMOR (TGCT) AND PRIOR COLONY-STIMULATING FACTOR 1 (CSF1) INHIBITOR THERAPY: A PHASE 2 CASE SERIES
Matthew Sherman
Favorite
(P 424) AN OPEN-LABEL PHASE 1/2 STUDY OF DCC-3009 MONOTHERAPY IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST)
Matthew Sherman
Favorite
shetty, om shree

Tata Memorial Hospital
(P 338) POORLY DIFFERENTIATED SYNOVIAL SARCOMA: A HISTOLOGIC CHALLENGE OF AN AGGRESSIVE VARIANT
om shree shetty
Favorite
(P 379) IMPACT OF EWSR1 GENE REARRANGEMENT TESTING ON DIAGNOSIS OF A WIDE RANGE OF SOLID TUMOURS
om shree shetty
Favorite
Shih, Helen

Massachusetts General Hospital
(P 461) A RETROSPECTIVE ANALYSIS OF PATIENTS WITH CONVENTIONAL CHORDOMA TREATED WITH SYSTEMIC THERAPY
Helen Shih
Favorite
Shimada, Eijiro

Duke University
(P 126) SINGLE-CELL RNA SEQUENCING AND PROTEOMIC SPATIAL PROFILING REVEAL COMPLEX TUMOR MICROENVIRONMENT AND NOVEL IMMUNE INTERACTIONS IN CHONDROSARCOMA
Eijiro Shimada
Favorite
(P 380) INVESTIGATING THE ROLE OF HISTONE DEACETYLASE-3 IN METASTATIC UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Eijiro Shimada
Favorite
(P 472) LANDSCAPE OF ULTRA-RARE SARCOMAS: A NATIONWIDE STUDY FOR EPIDEMIOLOGY AND PROGNOSIS
Eijiro Shimada
Favorite
Shimoi, Tatsunori

Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
(P 341) PROGNOSTIC RELEVANCE OF CYCLOPHOSPHAMIDE DOSE FOR HIGH-RISK RHABDOMYOSARCOMA IN ADULT PATIENTS TREATED WITH VAC THERAPY
Tatsunori Shimoi
Favorite
Shine, Robert

Apollo Therapeutics; Strand Therapeutics
(P 433) PHASE I DOSE ESCALATION TRIAL OF STX-001, AN LNP SELF-REPLICATING MRNA EXPRESSING IL-12, IN PATIENTS WITH REFRACTORY TUMORS INCLUDING SARCOMAS
Robert Shine
Favorite
Shin, Kyoungseob

Seoul National University
(P 175) INTERPRETABLE DEEP LEARNING BASED CLASSIFICATION OF SARCOMA IMMUNE SUBTYPES FROM H&E SLIDES FOR IMMUNOTHERAPY STRATIFICATION
Kyoungseob Shin
Favorite
(P 176) DEEP LEARNING MODEL FOR DIFFERENTIATING BETWEEN NEOPLASTIC PATHOLOGIC FRACTURE AND NONPATHOLOGIC FRACTURE FROM PLAIN HIP RADIOGRAPHS
Kyoungseob Shin
Favorite
Shin, Seung Han

Department of Orthopaedic Surgery, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
(P 171) THREE-DIMENSIONAL DEEP LEARNING MODEL FOR PREDICTING PROXIMAL FEMORAL PATHOLOGIC FRACTURE USING OPPORTUNISTIC ABDOMINOPELVIC CT IN PATIENTS WITH ADVANCED CANCER: A PRELIMINARY REPORT
Seung Han Shin
Favorite
Shishak, Sorun

Medanta the Medicity
(P 276) RADIATION-INDUCED SARCOMA (RIS): CLINICAL SPECTRUM AND ONCOLOGIC OUTCOMES FROM A TERTIARY INDIAN SARCOMA CLINIC
Sorun Shishak
Favorite
Shlien, Adam

The Hospital for Sick Children
(P 73) TARGETABLE GENE DEPENDENCIES IN EWING SARCOMA SUBTYPES
Adam Shlien
Favorite
(P 256) THE SEAN KARL COHORT: A NATIONAL COLLABORATIVE SINGLE-CELL RNASEQ STUDY OF PAIRED PATIENT EWING SARCOMA SPECIMENS
Adam Shlien
Favorite
Sholevar, Cyrus

Surgical Oncology, Department of Surgery, University of California, Davis
(P 244) INTRATUMORAL TIGIT BLOCKADE AUGMENTS ANTI-TUMOR RESPONSES AND BYPASSES HYPERFUNCTIONALITY OF PERIPHERAL TIGIT+ NK CELLS IN MOUSE AND HUMAN MODELS OF BONE AND SOFT TISSUE SARCOMA
Cyrus Sholevar
Favorite
(P 245) SUBTYPE SPECIFIC CHARACTERIZATION OF IMMUNE INFILTRATION IN SOFT TISSE SARCOMAS
Cyrus Sholevar
Favorite
Shulman, David

Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
(P 427) PHASE 1/2 TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF PEEL-224 IN COMBINATION WITH VINCRISTINE AND TEMOZOLOMIDE IN ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY SARCOMAS
David Shulman
Favorite
Shultz, David

Princess Margaret Cancer Centre
(P 57) STUDYING HYPOXIA-INDUCED METASTASIS IN GENETICALLY ENGINEERED MOUSE MODELS OF UPS
David Shultz
Favorite
(P 430) A PH/2 STUDY OF THE RADIOPHARMACEUTICAL [AC-225]RTX-2358 IN THE TREATMENT OF RELAPSED / REFRACTORY (R/R) SOFT TISSUE SARCOMA (STS) THE ATLAS STUDY - ACTINIUM THERAPY FOR LATE-STAGE AGGRESSIVE SARCOMAS
David Shultz
Favorite
Siatis, Dimitrios

Candiolo Cancer Institute, FPO – IRCCS
(P 328) INNOVATING SARCOMA EDUCATION: EARLY OUTCOMES OF THE ITALIAN SOCIETY OF SURGICAL ONCOLOGY (SICO) SARCOMA SOCIAL MULTI-PLATFORM JOURNAL CLUB INITIATIVE
Dimitrios Siatis
Favorite
Sicinska, Ewa

Dana-Farber
(P 198) EXPLOITING METABOLIC DYSREGULATION IN SUCCINATE DEHYDROGENASE-DEFICIENT GASTROINTESTINAL STROMAL TUMOR
Ewa Sicinska
Favorite
Sicklick, Jason

Dept. of Surgery, Moores Cancer Center, University of California San Diego
(P 179) NEOADJUVANT AVAPRITINIB IN PDGFRA-MUTANT GIST: NEAR COMPLETE PATHOLOGICAL RESPONSES AT THE COST OF HIGH ADVERSE EVENT RATES
Jason Sicklick
Favorite
(P 180) COMPARATIVE EFFICACY OF GENERIC AND BRAND-NAME IMATINIB IN NEOADJUVANT TREATMENT OF KIT EXON 11 MUTANT GIST
Jason Sicklick
Favorite
(P 197) DIFFERENTIAL EFFECTS OF ANAGRELIDE IN GASTROINTESTINAL STROMAL TUMORS (GIST) IN VITRO
Jason Sicklick
Favorite
(P 423) ZIFTOMENIB IN COMBINATION WITH IMATINIB IN ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST) AFTER IMATINIB FAILURE: PHASE 1A/B STUDY OF SAFETY, PHARMACOKINETICS, AND ANTITUMOR ACTIVITY
Jason Sicklick
Favorite
Sicoli, Federico

IRCCS Humanitas Research Hospital
(P 203) MINIMALLY INVASIVE RESECTION OF MULTIFOCAL DUODENO-JEJUNAL GISTS IN NEUROFIBROMATOSIS TYPE 1
Federico Sicoli
Favorite
(P 318) BURIED DE-EPITHELIALIZED FLAP RECONSTRUCTION AFTER WIDE EXCISION OF THIGH SARCOMAS: EARLY EXPERIENCE FROM A SPECIALIZED SARCOMA SURGERY UNIT
Federico Sicoli
Favorite
(P 339) POSTERIOR APPROACH FOR RADICAL RESECTION OF SACROCOCCYGEAL CHORDOMA: A SURGICAL PERSPECTIVE FROM A TERTIARY REFERRAL CENTER
Federico Sicoli
Favorite
(P 365) UROLOGICAL RECONSTRUCTION DURING RETROPERITONEAL AND PELVIC SARCOMA SURGERY: EXPERIENCE FROM A HIGH-VOLUME SARCOMA CENTER
Federico Sicoli
Favorite
Siddiquee, Armaan

Memorial Sloan Kettering Cancer Center
(P 237) DEVELOPMENT OF EPHA2 CAR T CELL THERAPY FOR OSTEOSARCOMA
Armaan Siddiquee
Favorite
(P 267) THE RAF/MEK INHIBITOR VS-6766 SHOWS EFFICACY IN RAS-MUTANT PEDIATRIC PRECLINICAL XENOGRAFT MODELS- A REPORT FROM THE PEDIATRIC PRECLINICAL IN VIVO TESTING CONSORTIUM
Armaan Siddiquee
Favorite
Siegel, Geoffrey

University of Michigan Rogel Comprehensive Cancer Center
(P 227) TREATMENT PATTERNS IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMORS: ADDRESSING COMMUNICATION IN A NEW THERAPEUTIC LANDSCAPE
Geoffrey Siegel
Favorite
Sihto, Harri

Dept. of Pathology, University of Helsinki and Helsinki University Hospital
(P 197) DIFFERENTIAL EFFECTS OF ANAGRELIDE IN GASTROINTESTINAL STROMAL TUMORS (GIST) IN VITRO
Harri Sihto
Favorite
Sikorski, Robert

Woodside Way Ventures
(P 440) CASE REPORT: COMPLETE CLINICAL AND MOLECULAR RESPONSE TO INTRATUMORAL STX-001, AN LNP-SELF REPLICATING MRNA EXPRESSING IL-12 IN A PATIENT WITH REFRACTORY ANGIOSARCOMA
Robert Sikorski
Favorite
Silberman, Allen

Cedars Sinai Medical Center
(P 230) CIRCULATING TUMOR DNA AS AN EARLY INDICATOR OF RESPONSE, PROGRESSION, AND RECURRENCE OF SARCOMAS
Allen Silberman
Favorite
(P 433) PHASE I DOSE ESCALATION TRIAL OF STX-001, AN LNP SELF-REPLICATING MRNA EXPRESSING IL-12, IN PATIENTS WITH REFRACTORY TUMORS INCLUDING SARCOMAS
Allen Silberman
Favorite
(P 440) CASE REPORT: COMPLETE CLINICAL AND MOLECULAR RESPONSE TO INTRATUMORAL STX-001, AN LNP-SELF REPLICATING MRNA EXPRESSING IL-12 IN A PATIENT WITH REFRACTORY ANGIOSARCOMA
Allen Silberman
Favorite
(P 471) COMBINATION CHEMOTHERAPY WITH GEMCITABINE AND PACLITAXEL: A HIGHLY EFFICACIOUS AND BETTER TOLERATED OPTION FOR ANGIOSARCOMA
Allen Silberman
Favorite
Silletta, Marianna

Fondazione Policlinico Campus Bio-medico di Roma
(P 412) UNCOVERING HER2 OVEREXPRESSION IN SOFT TISSUE SARCOMAS (STS): INSIGHTS FROM THE CANCER GENOME ATLAS (TCGA)
Marianna Silletta
Favorite
Silva, Carolina

Grupo Oncoclinicas
(P 285) MULTICENTER STUDY OF SPATIALLY FRACTIONATED RADIOTHERAPY (LATTICE) FOR LARGE-VOLUME RADIORESISTANT SARCOMAS
Carolina Silva
Favorite
Silvaggio, Maria

University of Pittsburgh
(P 63) EVALUATING SURGICAL MARGINS IN SARCOMA RESECTION WITH INDOCYANINE GREEN FLUORESCENCE IMAGING
Maria Silvaggio
Favorite
Silver, Kate

National Institutes of Health
(P 258) INVESTIGATING THE ROLE OF ALVEOLAR PNEUMOCYTES IN THE LUNG MICROENVIRONMENT OF OSTEOSARCOMA METASTASES
Kate Silver
Favorite
Silvia, Nadia

Stanford University
(P 400) LONGITUDINAL EPIGENETIC AND TRANSCRIPTOMIC REMODELING ACROSS PRIMARY, IRRADIATED, AND LOCALLY RELAPSED SOFT TISSUE SARCOMAS
Nadia Silvia
Favorite
Simões, Anderson

Federal University of São Paulo, São Paulo, Brazil
(P 404) OUTCOMES OF NEOADJUVANT THERAPY IN ANGIOSARCOMA PATIENTS: A KAPLAN-MEIER-RECONSTRUCTED INDIVIDUAL PATIENT-LEVEL META-ANALYSIS
Anderson Simões
Favorite
Simonelli, Leonardo

University of Miami Miller School of Medicine
(P 201) METASTATIC PATTERNS, TREATMENT MODALITIES, AND OVERALL SURVIVAL IN OLIGOMETASTATIC GIST: A SINGLE-CENTER RETROSPECTIVE STUDY
Leonardo Simonelli
Favorite
(P 369) CLINICAL CHARACTERISTICS & TREATMENT OUTCOME PATTERNS OF SOLITARY FIBROUS TUMORS: A SINGLE-INSTITUTION RETROSPECTIVE ANALYSIS
Leonardo Simonelli
Favorite
Simonetti, Sonia

Fondazione Policlinico Universitario Campus Bio-Medico
(P 61) HER2 TARGETING IN CHORDOMA: PRECLINICAL INSIGHTS ON TRASTUZUMAB DERUXTECAN
Sonia Simonetti
Favorite
Simon, Eugenio

University of Florida
(P 426) A PHASE I/II TRIAL USING RNA LIPID NANOPARTICLES FOR RECURRENT OSTEOSARCOMA: A REPORT FROM THE NATIONAL PEDIATRIC CANCER FOUNDATION
Eugenio Simon
Favorite
Singer, Samuel

Memorial Sloan Kettering Cancer Center
(P 409) RETROSPECTIVE ANALYSIS OF PROGNOSTIC FACTORS INCLUDING HLA GENOTYPE IN MYXOID LIPOSARCOMA
Samuel Singer
Favorite
(P 421) CHARACTERIZING THE IMMUNE RESPONSE TO INTRATUMORAL TIGILANOL TIGLATE (TT) IN PATIENTS WITH ADVANCED AND/OR METASTATIC SOFT TISSUE SARCOMA (STS) IN A PHASE IIA TRIAL (NCT05755113)
Samuel Singer
Favorite
Singh, Akash

AIIMS Delhi
(P 276) RADIATION-INDUCED SARCOMA (RIS): CLINICAL SPECTRUM AND ONCOLOGIC OUTCOMES FROM A TERTIARY INDIAN SARCOMA CLINIC
Akash Singh
Favorite
(P 468) CLINICAL UTILITY OF TARGETED NEXT-GENERATION SEQUENCING IN GUIDING SARCOMA DIAGNOSIS AND PERSONALIZED MANAGEMENT: A SINGLE-CENTER STUDY FROM INDIA
Akash Singh
Favorite
Singh, Arun

University of California
(P 315) ANALYSIS OF CHANGES IN T2-WEIGHTED SIGNAL INTENSITY AND TUMOR VOLUME AND EXPOSURE-RESPONSE IN THE RINGSIDE PHASE 2 STUDY OF VAREGACESTAT FOR DESMOID TUMORS
Arun Singh
Favorite
(P 410) SUBGROUP ANALYSIS OF THE PHASE 2 PART OF THE RINGSIDE PHASE 2/3 TRIAL OF VAREGACESTAT FOR TREATMENT OF DESMOID TUMORS
Arun Singh
Favorite
(P 430) A PH/2 STUDY OF THE RADIOPHARMACEUTICAL [AC-225]RTX-2358 IN THE TREATMENT OF RELAPSED / REFRACTORY (R/R) SOFT TISSUE SARCOMA (STS) THE ATLAS STUDY - ACTINIUM THERAPY FOR LATE-STAGE AGGRESSIVE SARCOMAS
Arun Singh
Favorite
Singh, Gursimar

Carnegie Mellon University
(P 14) EVALUATING THE COMBINATION OF DISULFIRAM AND ENZALUTAMIDE IN OSTEOSARCOMA
Gursimar Singh
Favorite
SINGH, KINJAL

All India Institute of Medical Sciences, Delhi, India
(P 276) RADIATION-INDUCED SARCOMA (RIS): CLINICAL SPECTRUM AND ONCOLOGIC OUTCOMES FROM A TERTIARY INDIAN SARCOMA CLINIC
KINJAL SINGH
Favorite
(P 468) CLINICAL UTILITY OF TARGETED NEXT-GENERATION SEQUENCING IN GUIDING SARCOMA DIAGNOSIS AND PERSONALIZED MANAGEMENT: A SINGLE-CENTER STUDY FROM INDIA
KINJAL SINGH
Favorite
Singh, Reena

Vanderbilt University Medical Center
(P 85) MAKING NEGATIVE MARGIN MUSCULOSKELETAL TUMOR SURGERY A VIRTUAL REALITY USING 3D SPECIMEN SCANNING
Reena Singh
Favorite
(P 310) ATYPICAL SPINDLE CELL PLEOMORPHIC LIPOMATOUS TUMORS OF THE RETROPERITONEUM ARE HETEROGENOUS: A REPORT OF FOUR DISPARATE CASES
Reena Singh
Favorite
Singh, Rishika

University of Virginia
(P 199) CHARACTERISTICS OF AN IMMUNOHISTOCHEMICAL AND MOLECULARLY DISCORDANT POPULATION OF GIST PATIENTS: A SINGLE CENTER RETROSPECTIVE REVIEW
Rishika Singh
Favorite
Siontis, Brittany

Mayo Clinic
(P 223) OUTCOMES OF GERIATRIC PATIENTS WITH DE NOVO SARCOMA AND LUNG METASTASES: ROLE OF TUMOR CHARACTERISTICS AND TREATMENT STRATEGY
Brittany Siontis
Favorite
(P 246) CTLA4 PATHWAY ACTIVATION IN RADIATION-INDUCED ANGIOSARCOMA: A TRANSCRIPTOMIC RATIONALE FOR IMMUNE CHECKPOINT BLOCKADE
Brittany Siontis
Favorite
(P 300) FEATURES AND OUTCOMES OF PATIENTS WITH GASTROINTESTINAL LEIYOMYOSARCOMA
Brittany Siontis
Favorite
(P 430) A PH/2 STUDY OF THE RADIOPHARMACEUTICAL [AC-225]RTX-2358 IN THE TREATMENT OF RELAPSED / REFRACTORY (R/R) SOFT TISSUE SARCOMA (STS) THE ATLAS STUDY - ACTINIUM THERAPY FOR LATE-STAGE AGGRESSIVE SARCOMAS
Brittany Siontis
Favorite
Sisakyan, Janna

Yerevan State Medical University
(P 158) GLOBAL INEQUITIES IN CHONDROSARCOMA CLINICAL TRIALS: A COMPREHENSIVE ANALYSIS ACROSS THREE DECADES
Janna Sisakyan
Favorite
Sittiju, Pattaralawan

Chiang Mai University, Thailand
(P 116) A DUAL-TARGETED SYSTEMIC THERAPEUTIC APPROACH FOR THE SELECTIVE ELIMINATION OF TUMOR CELLS IN PRIMARY AND METASTATIC SARCOMA.
Pattaralawan Sittiju
Favorite
Sivarajah, Gausihi

Royal Hobart Hospital
(P 414) PATTERNS OF RELAPSE OF BORDERLINE AND MALIGNANT PHYLLODES TUMOUR- RESULTS FROM SARCOMA REFERENCE CENTRE (SRC)
Gausihi Sivarajah
Favorite
Skinner, Mary

University of Michigan
(P 24) THE SIRTUIN SIRT5 SUPPORTS EWING SARCOMA SURVIVAL VIA REGULATION OF EWS-FLI1 STABILITY AND ACTIVITY
Mary Skinner
Favorite
Skoczylas, Jacek

Maria Sklodowska-Curie National Research Institute of Oncology
(P 313) SIGNIFICANCE OF LYMPH NODE PROCEDURES IN SOFT TISSUE SARCOMA PATIENTS
Jacek Skoczylas
Favorite
Skornja, Iris

university of amsterdam
(P 105) TREATMENT SUCCESS RATE AFTER SURGICAL MANAGEMENT OF PERIPROSTHETIC JOINT INFECTIONS IN ONCOLOGIC PROXIMAL TIBIA RECONSTRUCTION
Iris Skornja
Favorite
Skubitz, Keith

University of Minnesota
(P 418) INTEGRATING SARCULATOR AND PET RESPONSE TO GUIDE NEOADJUVANT TREATMENT DECISIONS IN HIGH-RISK SOFT TISSUE SARCOMA
Keith Skubitz
Favorite
Slater, Olga

Great Ormond Street Hospital for Children
(P 250) OUTCOME OF INFANTS WITH RHABDOMYOSARCOMA: A REPORT FROM THE INTERNATIONAL SOFT TISSUE SARCOMA CONSORTIUM
Olga Slater
Favorite
Sleator, Jade

St Vincent's University Hospital
(P 211) HEALTH-RELATED QUALITY OF LIFE IN IRISH SARCOMA PATIENTS
Jade Sleator
Favorite
(P 213) FINANCIAL TOXICITY IN IRISH SARCOMA CARE: A SINGLE-CENTRE ANALYSIS
Jade Sleator
Favorite
Sloan, Caroline

Duke University School of Medicine
(P 214) FINANCIAL TOXICITY IN PATIENTS WITH A HISTORY OF EXTREMITY AND PELVIC SARCOMA TREATMENT
Caroline Sloan
Favorite
Slopis, John

MD Anderson Cancer Center
(P 351) THE ROLE OF SOCIOECONOMIC DISPARITIES ON SURVIVAL OUTCOMES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
John Slopis
Favorite
Slotkin, Emily

Memorial Sloan Kettering Cancer Center
(P 265) MULTI-SITE SINGLE CELL TRANSCRIPTOMICS REVEAL DISTINCT IMMUNE INFILTRATIVE PATTERNS IN DESMOPLASTIC SMALL ROUND CELL TUMOR
Emily Slotkin
Favorite
Smith, Amber

Rare Cancer Research Foundation
(P 350) THE PATTERN.ORG SARCOMA CONSORTIUM: BUILDING A MULTI-INSTITUTIONAL DATA RESOURCE FOR THE SARCOMA RESEARCH COMMUNITY
Amber Smith
Favorite
Smith, Jimmy

UC Davis Health
(P 95) COMPARATIVE OUTCOMES OF OPERATIVE AND NON-OPERATIVE TREATMENT FOR METASTATIC HUMERAL PATHOLOGIC FRACTURES
Jimmy Smith
Favorite
(P 106) REPAIR: A PRELIMINARY REPORT ON AN ONGOING MULTI-CENTER TRIAL FOR PATIENTS UNDERGOING SURGICAL STABILIZATION FOR METASTATIC BONE DISEASE OF THE FEMUR
Jimmy Smith
Favorite
(P 349) THE COST OF SURVEILLANCE IN CALIFORNIA: MRI UTILIZATION IN RECURRENT EXTREMITY SOFT TISSUE SARCOMA
Jimmy Smith
Favorite
(P 360) MRI SURVEILLANCE PRACTICES AND RECURRENCE DETECTION IN EXTREMITY SOFT TISSUE SARCOMA: A RETROSPECTIVE STUDY
Jimmy Smith
Favorite
Smith, Kaitlyn

University of California San Francisco
(P 93) INTERCALARY COMPRESSIVE OSSEOINTEGRATION OF DIAPHYSEAL TUMORS: A MULTI-INSTITUTIONAL CASE SERIES
Kaitlyn Smith
Favorite
Smith, Malcolm

National Cancer Institute
(P 267) THE RAF/MEK INHIBITOR VS-6766 SHOWS EFFICACY IN RAS-MUTANT PEDIATRIC PRECLINICAL XENOGRAFT MODELS- A REPORT FROM THE PEDIATRIC PRECLINICAL IN VIVO TESTING CONSORTIUM
Malcolm Smith
Favorite
Smith, Megan

Deciphera Pharmaceuticals, LLC
(P 195) IMPACT OF EXPERT-LED EDUCATION PROGRAMS ON HEALTH CARE PROVIDER (HCP) KNOWLEDGE OF GASTROINTESTINAL STROMAL TUMOR (GIST)
Megan Smith
Favorite
Smith, Myles

Royal Marsden Hospital NHS Foundation Trust
(P 298) RESECTION OF PARA-RENAL INFERIOR VENA CAVA LEIOMYOSARCOMA WITH RIGHT NEPHRECTOMY AND LEFT RENAL VEIN LIGATION WITHOUT VENOUS RECONSTRUCTION.
Myles Smith
Favorite
(P 414) PATTERNS OF RELAPSE OF BORDERLINE AND MALIGNANT PHYLLODES TUMOUR- RESULTS FROM SARCOMA REFERENCE CENTRE (SRC)
Myles Smith
Favorite
Smith, Vanessa

University of Virginia
(P 199) CHARACTERISTICS OF AN IMMUNOHISTOCHEMICAL AND MOLECULARLY DISCORDANT POPULATION OF GIST PATIENTS: A SINGLE CENTER RETROSPECTIVE REVIEW
Vanessa Smith
Favorite
Smrke, Alannah

University of British Columbia
(P 178) TREATMENT RESPONSE AND SURVIVAL OUTCOMES IN GASTROINTESTINAL STROMAL TUMORS FOLLOWING NEOADJUVANT THERAPY
Alannah Smrke
Favorite
Sneed, Shay

St. Jude Children's Research Hospital
(P 267) THE RAF/MEK INHIBITOR VS-6766 SHOWS EFFICACY IN RAS-MUTANT PEDIATRIC PRECLINICAL XENOGRAFT MODELS- A REPORT FROM THE PEDIATRIC PRECLINICAL IN VIVO TESTING CONSORTIUM
Shay Sneed
Favorite
Sobczuk, Paweł

Maria Sklodowska-Curie National Research Institute of Oncology
(P 191) EFFICACY OF SYSTEMIC PALLIATIVE THERAPIES IN PATIENTS WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST) PREVIOUSLY TREATED WITH ADJUVANT IMATINIB - REAL-WORLD CLINICAL PRACTICE DATA
Paweł Sobczuk
Favorite
Solans Solerdelcoll, Mireia

Hospital de la Santa Creu i Sant Pau
(P 383) MULTIDISCIPLINARY TREATMENT OF INGUINOSCROTAL SARCOMAS: ANALYSIS OF 39 CASES TREATED BY SURGICAL APPROACH
Mireia Solans Solerdelcoll
Favorite
Solimini, Nicole

Dana-Farber Cancer Institute
(P 34) EXPRESSION OF ONCOFETAL ANTIGEN 5T4 IN SARCOMA SUBTYPES AND PRECLINICAL ACTIVITY OF TUB-030, A NOVEL 5T4-TARGETING ANTIBODY-DRUG CONJUGATE (ADC)
Nicole Solimini
Favorite
(P 235) AGNOSTIC INDICATION OF IMMUNE CHECKPOINT INHIBITORS (ICI): PATTERNS OF RESPONSE OF SARCOMAS
Nicole Solimini
Favorite
Solorzano, Felipe

Fundación Colombiana de Cancerología Clínica Vida
(P 219) RETROPERITONEAL SARCOMA: HEALTH SYSTEM BARRIERS AND THE RATIONALE FOR A SPECIALIZED SARCOMA UNIT
Felipe Solorzano
Favorite
(P 301) RETROPERITONEAL SARCOMA: SINGLE CENTER EXPERIENCE IN LATIN AMERICA. DO WE HAVE DIFFERENT SARCOMAS WHEN COMPARED TO THE REST OF THE WORLD?
Felipe Solorzano
Favorite
Somaiah, Neeta

Department of Sarcoma Medical Oncology, Division of Cancer Medicine, MD Anderson Cancer Center
(P 54) PRECLINICAL MODELS REVEALING MDM2-P53 INTERACTION AND DEPENDENCY FOR TUMOR CELL SURVIVAL IN WELL-DIFFERENTIATED (WD) AND DEDIFFERENTIATED (DD) LIPOSARCOMA (LPS).
Neeta Somaiah
Favorite
(P 83) OUTCOMES OF MULTIMODAL PERIOPERATIVE TREATMENT IN OSTEOSARCOMAS OF THE JAW
Neeta Somaiah
Favorite
(P 184) MTAP IN GASTROINTESTINAL STROMAL TUMOR (GIST): RATE OF MTAP LOSS AND CONCORDANCE BETWEEN GENOMIC SEQUENCING AND IMMUNOHISTOCHEMISTRY
Neeta Somaiah
Favorite
(P 194) UPDATED RESULTS FROM STRATEGIST 1: A PHASE 1/1B STUDY OF IDRX-42 (GSK6042981A) IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST)
Neeta Somaiah
Favorite
(P 242) IMMUNE PROFILING OF UNDIFFERENTIATED PLEOMORPHIC SARCOMAS REVEALS DISTINCT PROGNOSTIC SUBGROUPS
Neeta Somaiah
Favorite
(P 274) RACIAL DISPARITIES IN INCIDENCE AND MORTALITY OVER 20 YEARS AMONG AYA PATIENTS WITH SARCOMA IN THE US: A SEER DATABASE ANALYSIS
Neeta Somaiah
Favorite
(P 337) POOLED ANALYSIS OF TRABECTEDIN EFFICACY IN MYXOID/ROUND CELL LIPOSARCOMA FROM THREE PROSPECTIVE CLINICAL TRIALS
Neeta Somaiah
Favorite
(P 351) THE ROLE OF SOCIOECONOMIC DISPARITIES ON SURVIVAL OUTCOMES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Neeta Somaiah
Favorite
(P 430) A PH/2 STUDY OF THE RADIOPHARMACEUTICAL [AC-225]RTX-2358 IN THE TREATMENT OF RELAPSED / REFRACTORY (R/R) SOFT TISSUE SARCOMA (STS) THE ATLAS STUDY - ACTINIUM THERAPY FOR LATE-STAGE AGGRESSIVE SARCOMAS
Neeta Somaiah
Favorite
(P 451) TREATMENT OUTCOMES OF GEMCITABINE AND DOCETAXEL IN PATIENTS WITH CLEAR CELL SARCOMA (CCS) OR GASTROINTESTINAL NEUROECTODERMAL TUMOR (GNET): A CASE SERIES
Neeta Somaiah
Favorite
(P 460) OUTCOMES OF LATER-LINES SYSTEMIC THERAPIES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS (MPNST)
Neeta Somaiah
Favorite
Somarelli, Jason

Duke University Department of Medicine
(P 19) SERUM EXOSOMES IDENTIFY AN ABERRANT PROTEOMIC SIGNATURE IN CANINE OSTEOSARCOMA PRECEDING METASTATIC PROGRESSION
Jason Somarelli
Favorite
(P 119) DEVELOPMENT OF AN EXTINCTION THERAPY APPROACH FOR OSTEOSARCOMA USING ECO-EVOLUTIONARY PRINCIPLES
Jason Somarelli
Favorite
(P 125) TARGETING LCP1-MEDIATED METASTASIS IN CHONDROSARCOMA WITH OROXYLIN A
Jason Somarelli
Favorite
(P 130) INVESTIGATING LCP1-MEDIATED ONCOGENIC SIGNALING IN CHONDROSARCOMA METASTASIS
Jason Somarelli
Favorite
(P 259) PRECLINICAL MODELING OF CHEMOTHERAPY RELEASE IDENTIFIES MITOCHONDRIAL ADAPTATIONS IN DOXORUBICIN TREATED OSTEOSARCOMA
Jason Somarelli
Favorite
Song, Eric

Immunome, Inc.
(P 315) ANALYSIS OF CHANGES IN T2-WEIGHTED SIGNAL INTENSITY AND TUMOR VOLUME AND EXPOSURE-RESPONSE IN THE RINGSIDE PHASE 2 STUDY OF VAREGACESTAT FOR DESMOID TUMORS
Eric Song
Favorite
(P 410) SUBGROUP ANALYSIS OF THE PHASE 2 PART OF THE RINGSIDE PHASE 2/3 TRIAL OF VAREGACESTAT FOR TREATMENT OF DESMOID TUMORS
Eric Song
Favorite
Song, Hyojin

Cumming School of Medicine, University of Calgary
(P 238) INVESTIGATING HOW MACROPHAGES INFILTRATE THE TUMOUR MICROENVIRONMENT AND INFLUENCE THE EFFICACY OF CAR T THERAPY IN A MURINE MODEL OF STS
Hyojin Song
Favorite
(P 378) HIGH DOSE RADIATION THERAPY PROMOTES IMMUNE SUPPRESSIVE MACROPHAGE PHENOTYPES, WHEREAS LOW DOSE RADIATION THERAPY PROMOTES IMMUNOGENIC MACROPHAGE PHENOTYPES IN A MURINE MODEL OF SOFT TISSUE SARCOMA
Hyojin Song
Favorite
Song, Julia

Brigham and Women's Hospital
(P 228) FREQUENCY AND CLARITY OF SURGICAL GOALS FOR TUMOR RESECTION IN ADVANCED SARCOMA
Julia Song
Favorite
Sonkin, Ben

Penn State University
(P 85) MAKING NEGATIVE MARGIN MUSCULOSKELETAL TUMOR SURGERY A VIRTUAL REALITY USING 3D SPECIMEN SCANNING
Ben Sonkin
Favorite
Soto Pernudi, Susan

Hospital México
(P 306) PROGNOSTIC NUTRITIONAL INDEX PREDICTS MAJOR POSTOPERATIVE COMPLICATIONS IN RETROPERITONEAL SARCOMA: RESULTS FROM THE LATAMSARC COHORT
Susan Soto Pernudi
Favorite
Soudi, Shaghayegh

Stanford University
(P 400) LONGITUDINAL EPIGENETIC AND TRANSCRIPTOMIC REMODELING ACROSS PRIMARY, IRRADIATED, AND LOCALLY RELAPSED SOFT TISSUE SARCOMAS
Shaghayegh Soudi
Favorite
Souza, Mariana

A.C.Camargo Cancer Center
(P 132) MOLECULAR LANDSCAPE AND CLINICAL HETEROGENEITY OF BRAZILIAN CHONDROSARCOMAS: INSIGHTS FROM IDH, TERT, AND GENOME-WIDE ANALYSIS
Mariana Souza
Favorite
(P 137) GENOMIC ALTERATIONS IN RARE CARTILAGINOUS TUMOR SYNDROMES ASSOCIATED WITH CHONDROSARCOMA DEVELOPMENT
Mariana Souza
Favorite
Sowell, Ryan

Strand Therapeutics Inc.
(P 433) PHASE I DOSE ESCALATION TRIAL OF STX-001, AN LNP SELF-REPLICATING MRNA EXPRESSING IL-12, IN PATIENTS WITH REFRACTORY TUMORS INCLUDING SARCOMAS
Ryan Sowell
Favorite
(P 440) CASE REPORT: COMPLETE CLINICAL AND MOLECULAR RESPONSE TO INTRATUMORAL STX-001, AN LNP-SELF REPLICATING MRNA EXPRESSING IL-12 IN A PATIENT WITH REFRACTORY ANGIOSARCOMA
Ryan Sowell
Favorite
Sowers, Madison

University of Florida
(P 248) AN EX VIVO ASSAY TO PREDICT IMMUNOTHERAPY RESPONSE IN SARCOMA
Madison Sowers
Favorite
Spałek, Mateusz

Maria Sklodowska-Curie National Research Institute of Oncology; Warsaw Poland
(P 216) VIRTUAL MULTIDISCIPLINARY MEETINGS IN THE CARE OF SARCOMA PATIENTS
Mateusz Spałek
Favorite
SPALATO CERUSO, Mariella

Institut Bergonié
(P 59) TARGETING ADORA2B TO HALT METASTASIS IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA: FROM MULTI-OMICS TO THERAPEUTIC INHIBITION
Mariella SPALATO CERUSO
Favorite
Spalek, Mateusz

Maria Sklodowska-Curie National Research Institute of Oncology
(P 27) MOLECULAR CHARACTERIZATION OF RESPONSE TO NEOADJUVANT CHEMORADIATION IN PATIENTS WITH LOCALLY ADVANCED SOFT TISSUE SARCOMAS
Mateusz Spalek
Favorite
(P 146) LOCALISED CHONDROSARCOMA PERIOPERATIVE TREATMENT: REAL-WORLD OUTCOMES AND CHALLENGES ACROSS HISTOLOGIC SUBTYPES
Mateusz Spalek
Favorite
(P 152) EFFICACY OF PALLIATIVE CHEMOTHERAPY AND LOCAL TREATMENTS IN ADVANCED CHONDROSARCOMA: A SUBTYPE-SPECIFIC RETROSPECTIVE ANALYSIS
Mateusz Spalek
Favorite
Spanheimer, Philip M.

UNC
(P 350) THE PATTERN.ORG SARCOMA CONSORTIUM: BUILDING A MULTI-INSTITUTIONAL DATA RESOURCE FOR THE SARCOMA RESEARCH COMMUNITY
Philip M. Spanheimer
Favorite
Sparber-Sauer, Monika

Stuttgart Cancer Center
(P 250) OUTCOME OF INFANTS WITH RHABDOMYOSARCOMA: A REPORT FROM THE INTERNATIONAL SOFT TISSUE SARCOMA CONSORTIUM
Monika Sparber-Sauer
Favorite
Sparks, Othneil

UCLA DGSOM
(P 16) MITOCHONDRIAL GENETIC VARIATION ORCHESTRATES COPZ1 TRANSCRIPT HETEROGENEITY AND REVEALS TELOMERE-MEDIATED VULNERABILITIES IN OSTEOSARCOMA
Othneil Sparks
Favorite
(P 72) COUNTY-LEVEL ASSOCIATIONS BETWEEN AIRBORNE TOXICANT EMISSIONS AND EWING SARCOMA DIAGNOSIS IN THE UNITED STATES
Othneil Sparks
Favorite
(P 81) ASSESSING PROGNOSTIC FACTORS OF CAUSE-SPECIFIC SURVIVAL IN PATIENTS WITH MALIGNANT GIANT CELL TUMORS: A POPULATION BASED STUDY FROM THE SEER DATABASE
Othneil Sparks
Favorite
(P 92) PRIMARY TUMOR SIZE AS AN INDEPENDENT PROGNOSTIC FACTOR IN OSTEOSARCOMA: PROPENSITY SCORE-MATCHED ANALYSIS DEMONSTRATES A CONTINUOUS DOSE-RESPONSE RELATIONSHIP
Othneil Sparks
Favorite
(P 100) THE ROLE OF CANCER TYPE IN THE DEVELOPMENT OF PERIPROSTHETIC JOINT INFECTION IN DISTAL FEMORAL REPLACEMENT
Othneil Sparks
Favorite
(P 107) IS THERE A BETTER OPTION: INTRAMEDULLARY NAIL VERSUS PLATE OSTEOSYNTHESIS FOR PATHOLOGIC HUMERAL FRACTURES?
Othneil Sparks
Favorite
(P 108) DISTANCE WEIGHTED MATCHING IN THE QUANTIFICATION OF EXCESS MORBIDITY IN EXTERNAL HEMIPELVECTOMY AND HIP DISARTICULATION
Othneil Sparks
Favorite
(P 157) INCOME IMPACTS OVERALL BUT NOT CAUSE-SPECIFIC SURVIVAL IN PATIENTS WITH CHONDROSARCOMA: A POPULATION BASED STUDY FROM THE SEER DATABASE
Othneil Sparks
Favorite
(P 232) IS THERE A ROLE FOR POSITRON EMISSION TOMOGRAPHY IN THE STAGING OF LANGERHANS CELL HISTIOCYTOSIS?
Othneil Sparks
Favorite
(P 384) PELVIC LOCATION PREDICTS WORSE OUTCOMES IN ALVEOLAR RHABDOMYOSARCOMA: UNDERUSE OF RADIOTHERAPY AND MISSED SURVIVAL BENEFIT
Othneil Sparks
Favorite
Speer, Tobias

Independent Researcher
(P 165) EVALUATING LARGE LANGUAGE MODELS AS DECISION SUPPORT TOOLS IN MULTIDISCIPLINARY TUMOR BOARDS FOR GASTROINTESTINAL STROMAL TUMORS
Tobias Speer
Favorite
Spencer, Christine

Rare Cancer Research Foundation
(P 350) THE PATTERN.ORG SARCOMA CONSORTIUM: BUILDING A MULTI-INSTITUTIONAL DATA RESOURCE FOR THE SARCOMA RESEARCH COMMUNITY
Christine Spencer
Favorite
Spentzos, Dimitrios

Massachusetts General Hospital
(P 17) EXTRASKELETAL OSTEOSARCOMA: MICRORNA PATTERNS PROVIDE INSIGHTS INTO SIMILARITIES AND CONTRASTS WITH OTHER SARCOMAS
Dimitrios Spentzos
Favorite
Spickard, Erik

Natera
(P 04) EARLY ON-TREATMENT CIRCULATING TUMOR DNA DYNAMICS TO PREDICT RESPONSE IN PATIENTS WITH SARCOMA
Erik Spickard
Favorite
Spiguel, Andre

Univeristy of Florida
(P 129) HIJACKED FUEL: GLYCOGEN-DRIVEN METABOLIC SHIFTS IN IDH1-MUTANT CHONDROSARCOMA
Andre Spiguel
Favorite
(P 220) THE IMPACT OF WOUND HEALING COMPLICATIONS ON PATIENT-REPORTED OUTCOMES FOLLOWING SOFT TISSUE SARCOMA SURGERY
Andre Spiguel
Favorite
Spinner, William

Adaptimmune
(P 247) SINGLE-CELL RNA SEQUENCING OF AFAMITRESGENE AUTOLEUCEL INDICATES MECHANISMS OF PERSISTENCE AND ANTI-TUMOR ACTIVITY
William Spinner
Favorite
Spruill, Laura

Medical University of South Carolina
(P 279) IMPACT OF PREOPERATIVE 5-DAY HYPOFRACTIONATED RADIOTHERAPY (HFRT) FOR SOFT TISSUE SARCOMA (STS) ON BARRIERS TO TREATMENT AT A HIGH-VOLUME SARCOMA CENTER (HV-SC)
Laura Spruill
Favorite
Sreenath, Dr. Nihanty

Saroj Gupta Cancer Centre and Research Institute
(P 468) CLINICAL UTILITY OF TARGETED NEXT-GENERATION SEQUENCING IN GUIDING SARCOMA DIAGNOSIS AND PERSONALIZED MANAGEMENT: A SINGLE-CENTER STUDY FROM INDIA
Dr. Nihanty Sreenath
Favorite
Sridhar, Sindhura

Vanderbilt University Medical Center
(P 85) MAKING NEGATIVE MARGIN MUSCULOSKELETAL TUMOR SURGERY A VIRTUAL REALITY USING 3D SPECIMEN SCANNING
Sindhura Sridhar
Favorite
Srikanthan, Amirrtha

Department of Medical Oncology, The Ottawa Hospital, Ottawa, ON, Canada
(P 395) ERIBULIN IN RECURRENT PRETREATED METASTATIC SOFT TISSUE SARCOMA. A CANADIAN SARCOMA RESEARCH AND CLINICAL COLLABORATION (CANSARCC) REAL WORLD ANALYSIS
Amirrtha Srikanthan
Favorite
Stacchiotti, Silvia

Fondazione IRCCS Istituto Nazionale dei Tumori
(P 32) EFFECTIVENESS OF LURBINECTEDIN PLUS IRINOTECAN IN PRECLINICAL MODEL OF DESMOPLASTIC SMALL ROUND CELL TUMOR
Silvia Stacchiotti
Favorite
(P 128) ISOCITRATE DEHYDROGENASE 1 (IDH1) MUTATION TESTING IN THE PHASE 3 STUDY OF IVOSIDENIB VS PLACEBO IN IDH1-MUTANT CONVENTIONAL CHONDROSARCOMA (CHONQUER)
Silvia Stacchiotti
Favorite
(P 210) TOWARDS INTERNATIONALIZATION OF THE CLINICAL RESEARCH COORDINATOR ROLE: THE FIRST DROP OF THE NIAGARA FALLS PROJECT
Silvia Stacchiotti
Favorite
(P 231) INCREASED LIFETIME RISK (LTR) OF SOFT TISSUE SARCOMAS (STS) IN PATIENTS WITH LOW-RISK GASTROINTESTINAL STROMAL TUMORS (GIST): A RETROSPECTIVE ANALYSIS FROM THE ITALIAN SARCOMA GROUP (ISG)
Silvia Stacchiotti
Favorite
Stacchiotti, Silvia

Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan
(P 277) THE ROLE OF RADIOTHERAPY IN THE MULTIDISCIPLINARY MANAGEMENT OF RADIATION-ASSOCIATED ANGIOSARCOMA OF THE BREAST: A REFERRAL CENTER EXPERIENCE
Silvia Stacchiotti
Favorite
Stacchiotti, Silvia

Fondazione IRCCS Istituto Nazionale dei Tumori
(P 308) IMPACT OF PSOAS MUSCLE RESECTION ON OUTCOMES IN PRIMARY RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMA
Silvia Stacchiotti
Favorite
(P 407) PIMICOTINIB IN TENOSYNOVIAL GIANT CELL TUMOR (TGCT): LONG-TERM EFFICACY, SAFETY, AND PATIENT-REPORTED OUTCOMES FROM THE PHASE 3 MANEUVER STUDY
Silvia Stacchiotti
Favorite
(P 416) A PHASE 2 MULTICENTER OPEN-LABEL BASKET STUDY OF TAZEMETOSTAT IN ADULT PATIENTS WITH INI1-NEGATIVE EPITHELIOID SARCOMA – FINAL ANALYSIS
Silvia Stacchiotti
Favorite
(P 422) EFFICACY WITH VIMSELTINIB IN PATIENTS (PTS) WITH TENOSYNOVIAL GIANT CELL TUMOR (TGCT) AND PRIOR COLONY-STIMULATING FACTOR 1 (CSF1) INHIBITOR THERAPY: A PHASE 2 CASE SERIES
Silvia Stacchiotti
Favorite
(P 446) GDF-15 AS A PROGNOSTIC FACTOR IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA
Silvia Stacchiotti
Favorite
(P 447) PAIN ASSESSMENT CRITERIA (PAC) ANTICIPATE RECIST PROGRESSION AND CORRELATE WITH BLOOD LEVELS OF GROWTH DIFFERENTIATION FACTOR 15 (GDF15) IN EPITHELIOID HEMANGIOENDOTHELIOMA (EHE)
Silvia Stacchiotti
Favorite
(P 452) EFFECTIVENESS OF ERIBULIN FOR MYXOID PLEOMORPHIC LIPOSARCOMA: INSIGHTS FROM A PATIENT-DERIVED MODEL AND CLINICAL TRANSLATION IN A PATIENT WITH ADVANCED DISEASE
Silvia Stacchiotti
Favorite
(P 458) BETWEEN LYMPHOMAS AND SARCOMAS: A RETROSPECTIVE, MULTI-INSTITUTIONAL STUDY FROM THE ITALIAN SARCOMA GROUP (ISG) ON HISTIOCYTIC AND DENDRITIC CELL NEOPLASMS (HDCN)
Silvia Stacchiotti
Favorite
(P 464) EFFICACY OUTCOMES AMONG PATIENTS WITH ADVANCED EPITHELIOID SARCOMAS OF PROXIMAL-TYPE AND DISTAL-TYPE TREATED WITH TAZ: POST HOC ANALYSIS OF STUDY EZH-202
Silvia Stacchiotti
Favorite
Stammberger, Antonia

Institute of Immunology, Faculty of Medicine Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany
(P 243) CLINICAL SIGNIFICANCE OF TUMOR-INFILTRATING IMMUNE CELL SUBSETS IN THE RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMAS AND LEIOMYOSARCOMAS
Antonia Stammberger
Favorite
Stearns, Timothy

PIVOT Coordinating Center
(P 267) THE RAF/MEK INHIBITOR VS-6766 SHOWS EFFICACY IN RAS-MUTANT PEDIATRIC PRECLINICAL XENOGRAFT MODELS- A REPORT FROM THE PEDIATRIC PRECLINICAL IN VIVO TESTING CONSORTIUM
Timothy Stearns
Favorite
Steeghs, Neeltje

Department of Medical Oncology, Netherlands Cancer Institute and Department of Medical Oncology, University Medical Center Utrecht
(P 41) THE IMPACT OF PAZOPANIB AND EXTREMITY RADIOTHERAPY ON TRANSAMINASES
Neeltje Steeghs
Favorite
(P 194) UPDATED RESULTS FROM STRATEGIST 1: A PHASE 1/1B STUDY OF IDRX-42 (GSK6042981A) IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST)
Neeltje Steeghs
Favorite
Steegmaier, Martin

Sotio Biotech a.s.
(P 257) TARGETING LEUCINE-RICH REPEAT-CONTAINING PROTEIN 15 (LRRC15): SOT106 ANTIBODY-DRUG CONJUGATE FOR SOFT TISSUE SARCOMA AND OSTEOSARCOMA TREATMENT
Martin Steegmaier
Favorite
Steffner, Robert

Stanford University
(P 400) LONGITUDINAL EPIGENETIC AND TRANSCRIPTOMIC REMODELING ACROSS PRIMARY, IRRADIATED, AND LOCALLY RELAPSED SOFT TISSUE SARCOMAS
Robert Steffner
Favorite
Steinberg, Jeffrey

St. Jude Children's Research Hospital
(P 241) MACROPHAGE INHIBITION ENHANCES PERIPHERAL CAR T CELL EXPANSION AND TUMOR CONTROL IN A PATIENT-DERIVED HUMANIZED MODEL OF AUTOLOGOUS CAR T CELL EFFICACY IN PEDIATRIC OSTEOSARCOMA (OS)
Jeffrey Steinberg
Favorite
Stein, Jacob

UNC
(P 350) THE PATTERN.ORG SARCOMA CONSORTIUM: BUILDING A MULTI-INSTITUTIONAL DATA RESOURCE FOR THE SARCOMA RESEARCH COMMUNITY
Jacob Stein
Favorite
Stenehjem, David

Department of Pharmacy Practice and Pharmaceutical Sciences, College of Pharmacy, University of Minnesota
(P 357) DEVELOPMENT OF AN ALGORITHM TO IDENTIFY PATIENTS (PT) WITH DESMOID TUMORS (DT) IN A UNITED STATES (US) CLAIMS DATASET
David Stenehjem
Favorite
Sterba, Katherine

Medical University of South Carolina
(P 279) IMPACT OF PREOPERATIVE 5-DAY HYPOFRACTIONATED RADIOTHERAPY (HFRT) FOR SOFT TISSUE SARCOMA (STS) ON BARRIERS TO TREATMENT AT A HIGH-VOLUME SARCOMA CENTER (HV-SC)
Katherine Sterba
Favorite
Stern, Sydney

TGCT Support/ Life Raft Group
(P 226) REAL-WORLD MANAGEMENT OF SYMPTOMATIC VS ASYMPTOMATIC TGCT FROM AN OBSERVATIONAL REGISTRY
Sydney Stern
Favorite
Steuerwald, Nury

Atrium Health Levine Cancer Institute
(P 02) METHYLATION PROFILING AS A DIAGNOSTIC ADJUNCT FOR UNDIFFERENTIATED SARCOMAS: A REAL-WORLD EVALUATION
Nury Steuerwald
Favorite
Stevenson, Jonathan

The Royal Orthopaedic Hospital NHS Foundation Trust
(P 136) ESTROGEN HAS A PROTECTIVE EFFECT ON CHONDROSARCOMA GROWTH IN VITRO AND IN VIVO
Jonathan Stevenson
Favorite
Stewart, Elizabeth

St. Jude Children's Research Hospital
(P 08) BUILDING A MEDICAL DONATION NETWORK TO ENHANCE DEVELOPMENT OF PEDIATRIC TUMOR MODELS
Elizabeth Stewart
Favorite
(P 267) THE RAF/MEK INHIBITOR VS-6766 SHOWS EFFICACY IN RAS-MUTANT PEDIATRIC PRECLINICAL XENOGRAFT MODELS- A REPORT FROM THE PEDIATRIC PRECLINICAL IN VIVO TESTING CONSORTIUM
Elizabeth Stewart
Favorite
Stockfisch, Emily

MSKCC
(P 256) THE SEAN KARL COHORT: A NATIONAL COLLABORATIVE SINGLE-CELL RNASEQ STUDY OF PAIRED PATIENT EWING SARCOMA SPECIMENS
Emily Stockfisch
Favorite
Stokes, Matthew

Cell Signaling Technology
(P 198) EXPLOITING METABOLIC DYSREGULATION IN SUCCINATE DEHYDROGENASE-DEFICIENT GASTROINTESTINAL STROMAL TUMOR
Matthew Stokes
Favorite
Stosky, Jordan

Arnie Charbonneau Cancer Institute and McCaig Institute for Bone and Joint Health
(P 378) HIGH DOSE RADIATION THERAPY PROMOTES IMMUNE SUPPRESSIVE MACROPHAGE PHENOTYPES, WHEREAS LOW DOSE RADIATION THERAPY PROMOTES IMMUNOGENIC MACROPHAGE PHENOTYPES IN A MURINE MODEL OF SOFT TISSUE SARCOMA
Jordan Stosky
Favorite
Strübing, Felix

Department of Hand, Plastic and Reconstructive Surgery, Microsurgery, Burn Trauma Center, BG Trauma Center Ludwigshafen, University of Heidelberg, Ludwigshafen, 67071 Germany.
(P 454) TREATMENT PATTERNS AND OUTCOMES IN RADIATION-INDUCED SARCOMA: FIRST RESULTS OF THE TETRIS-PROJECT - A MULTIMODAL RETROSPECTIVE ANALYSIS FROM A TERTIARY CENTER
Felix Strübing
Favorite
Strauss, Dirk

The Royal Marsden Hospital NHS Foundation Trust
(P 298) RESECTION OF PARA-RENAL INFERIOR VENA CAVA LEIOMYOSARCOMA WITH RIGHT NEPHRECTOMY AND LEFT RENAL VEIN LIGATION WITHOUT VENOUS RECONSTRUCTION.
Dirk Strauss
Favorite
(P 414) PATTERNS OF RELAPSE OF BORDERLINE AND MALIGNANT PHYLLODES TUMOUR- RESULTS FROM SARCOMA REFERENCE CENTRE (SRC)
Dirk Strauss
Favorite
Strauss, Morgen

Providence Cancer Institute
(P 58) PLK1 AS A VULNERABLE TARGET OF BAP1-DRIVEN UNDIFFERENTIATED PLEOMORPHIC SARCOMAS
Morgen Strauss
Favorite
Strauss, Sandra

UCL Cancer Institute, London, UK
(P 156) CHONDROSARCOMA INCIDENCE, SURVIVAL AND MANAGEMENT IN ENGLAND 2013-2022; AN ANALYSIS FROM THE NATIONAL DISEASE REGISTRATION SERVICE
Sandra Strauss
Favorite
Streller, Tino

Radiation Oncology LUKS
(P 282) LOCAL FAILURE ANALYSIS OF SOFT TISSUE SARCOMA TREATED WITH PREOPERATIVE ULTRA-HYPOFRACTIONATED RADIATION: UPDATE
Tino Streller
Favorite
(P 283) PALLIATIVE LATTICE RADIATION THERAPY IN SOFT TISSUE SARCOMA VERSUS CARCINOMA AND MELANOMA: OUTCOME COMPARISON
Tino Streller
Favorite
Strike, Sarah

Moffitt Cancer Center
(P 307) STRATEGIES FOR DATA QUALITY IN TARPSWG RETROPERITONEAL SARCOMA REGISTRY (RESAR)
Sarah Strike
Favorite
(P 394) DUAL OR TRIMODALITY THERAPY VERSUS SURGERY ALONE IN RADIATION-ASSOCIATED ANGIOSARCOMA OF THE BREAST
Sarah Strike
Favorite
(P 453) OUTCOMES OF PLEOMORPHIC LIPOSARCOMA PATIENTS FOLLOWING MULTI-DISCIPLINARY MANAGEMENT WITHIN A TERTIARY CANCER CENTER
Sarah Strike
Favorite
Strohmeyer, Ava

Duke University
(P 125) TARGETING LCP1-MEDIATED METASTASIS IN CHONDROSARCOMA WITH OROXYLIN A
Ava Strohmeyer
Favorite
(P 130) INVESTIGATING LCP1-MEDIATED ONCOGENIC SIGNALING IN CHONDROSARCOMA METASTASIS
Ava Strohmeyer
Favorite
Strong, Laura

Parabilis Medicines
(P 415) A PHASE 1/2 TRIAL OF FOG-001, A FIRST-IN-CLASS DIRECT β-CATENIN:TCF4 INHIBITOR: SAFETY AND PRELIMINARY ANTITUMOR ACTIVITY IN PATIENTS WITH DESMOID TUMORS (DT)
Laura Strong
Favorite
Studenski, Matthew

University of Miami, Department of Radiation Oncology
(P 289) SIX YEAR FOLLOW-UP ON CIVASHEET® USE FOR SOFT TISSUE SARCOMA: A SINGLE INSTITUTION EXPERIENCE
Matthew Studenski
Favorite
Studer, Gabriela

Luzerner Kantonsspital, Klinik für Radio-Onkologie
(P 215) SHAPEHUB: A MULTICENTRE REAL-WORLD-TIME DATA PLATFORM WITH DIGITAL TWIN ENGINE FOR A LEARNING HEALTH SYSTEM IN SARCOMA
Gabriela Studer
Favorite
(P 282) LOCAL FAILURE ANALYSIS OF SOFT TISSUE SARCOMA TREATED WITH PREOPERATIVE ULTRA-HYPOFRACTIONATED RADIATION: UPDATE
Gabriela Studer
Favorite
(P 283) PALLIATIVE LATTICE RADIATION THERAPY IN SOFT TISSUE SARCOMA VERSUS CARCINOMA AND MELANOMA: OUTCOME COMPARISON
Gabriela Studer
Favorite
(P 285) MULTICENTER STUDY OF SPATIALLY FRACTIONATED RADIOTHERAPY (LATTICE) FOR LARGE-VOLUME RADIORESISTANT SARCOMAS
Gabriela Studer
Favorite
Stutz, Emanuel

Inselspital, Bern University Hospital, University of Bern, Bern
(P 436) SAKK 57/24 FEASIBILITY OF TOTAL NEOADJUVANT TREATMENT WITH HYPERTHERMIA IN PATIENTS WITH HIGH-RISK EXTREMITY AND TRUNK SOFT TISSUE SARCOMA. A MULTICENTER, SINGLE ARM, OPEN LABEL, PHASE II TRIAL
Emanuel Stutz
Favorite
Styves, Hugo

Division of Hematology, Oncology and Cellular Therapy, Department of Medicine, Hôpital Maisonneuve-Rosemont, Université de Montréal, Montreal, Quebec, Canada.
(P 395) ERIBULIN IN RECURRENT PRETREATED METASTATIC SOFT TISSUE SARCOMA. A CANADIAN SARCOMA RESEARCH AND CLINICAL COLLABORATION (CANSARCC) REAL WORLD ANALYSIS
Hugo Styves
Favorite
Subhawong, Ty

University of Miami
(P 147) CONVENTIONAL AND DEDIFFERENTIATED CHONDROSARCOMA; IS ENCHONDROMA THE PRECURSOR LESION?
Ty Subhawong
Favorite
(P 289) SIX YEAR FOLLOW-UP ON CIVASHEET® USE FOR SOFT TISSUE SARCOMA: A SINGLE INSTITUTION EXPERIENCE
Ty Subhawong
Favorite
(P 397) EXPLORING REAL WORLD DATA OF RECURRENCE IN NON-METASTATIC MYXOFIBROSAROMA: AN UPDATED RETROSPECTIVE COHORT STUDY
Ty Subhawong
Favorite
subing, guo

Department of Anesthesiology，Peking University Medical Rehabilitation Hospital
(P 469) THE IMPACT OF PREOPERATIVE ANEMIA ON POSTOPERATIVE COMPLICATIONS AND SHORT-TERM PROGNOSIS IN RETROPERITONEAL TUMOR SURGERY PATIENTS.
guo subing
Favorite
Subramaniam, Vignesh

University of Florida
(P 248) AN EX VIVO ASSAY TO PREDICT IMMUNOTHERAPY RESPONSE IN SARCOMA
Vignesh Subramaniam
Favorite
Subramanian, Ajay

Stanford University
(P 400) LONGITUDINAL EPIGENETIC AND TRANSCRIPTOMIC REMODELING ACROSS PRIMARY, IRRADIATED, AND LOCALLY RELAPSED SOFT TISSUE SARCOMAS
Ajay Subramanian
Favorite
Sudo, Kazuki

Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
(P 341) PROGNOSTIC RELEVANCE OF CYCLOPHOSPHAMIDE DOSE FOR HIGH-RISK RHABDOMYOSARCOMA IN ADULT PATIENTS TREATED WITH VAC THERAPY
Kazuki Sudo
Favorite
Suh, Yang-Gun

National Cancer Center
(P 296) PULMONARY CEMENT EMBOLISM ASSOCIATED WITH PERCUTANEOUS CEMENTOPLASTY FOR BONE METASTASIS: MECHANISMS AND PROTECTIVE FACTORS
Yang-Gun Suh
Favorite
Sulem, Eva

Gustave roussy
(P 299) RECURRENCES AFTER PRIMARY RPS SURGERY IN A HIGH-VOLUME SARCOMA CENTER: A RETROSPECTIVE ANALYSIS ON 402 PATIENTS
Eva Sulem
Favorite
Sullivan, Ciara

Massachusetts General Hospital
(P 173) DEVELOPMENT AND EXTERNAL VALIDATION OF A MACHINE LEARNING ALGORITHM TO PREDICT OVERALL SURVIVAL IN PATIENTS WITH PELVIC OR APPENDICULAR LIPOSARCOMA
Ciara Sullivan
Favorite
Sullivan, Francis

Cogent Biosciences
(P 425) BEZUCLASTINIB EXPANDED ACCESS PROGRAM (EAP) FOR PATIENTS WITH GASTROINTESTINAL STROMAL TUMORS (GIST)
Francis Sullivan
Favorite
Sullivan, Mikaela

Mayo Clinic
(P 150) LOCAL RECURRENCE OF CHONDROSARCOMA: IMPACT ON SURVIVAL AND RECURRENCE AT AN INCREASED GRADE
Mikaela Sullivan
Favorite
Sullivan, Mikaela

Mayo Clinic, Rochester
(P 162) CHONDROSARCOMA OUTCOMES IN YOUNG VERSUS ADULT POPULATIONS
Mikaela Sullivan
Favorite
Sullivan, Molly

NCI/NIH
(P 181) THE DEVELOPMENT OF A NOVEL PDGFRA RESISTANCE MUTATION IN A RECURRENT KIT-MUTANT GASTROINTESTINAL STROMAL TUMOR (GIST)
Molly Sullivan
Favorite
Sundaram, Ranjini

Yale School of Medicine
(P 40) PRECLINICAL EFFICACY OF A PH-SENSITIVE EXATECAN PEPTIDE-DRUG-CONJUGATE IN RHABDOMYOSARCOMA
Ranjini Sundaram
Favorite
Sun, Ramon C.

University of Florida
(P 129) HIJACKED FUEL: GLYCOGEN-DRIVEN METABOLIC SHIFTS IN IDH1-MUTANT CHONDROSARCOMA
Ramon C. Sun
Favorite
Sun, Steven

Sutter West Bay Medical Group
(P 309) RETROPERITONEAL LIPOMAS: MULTICENTER CLINICAL EXPERIENCE WITH AN EXTREMELY RARE DISEASE ENTITY
Steven Sun
Favorite
Sun, Wei

Department of Orthopaedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
(P 07) A LIVING MULTI-OMICS BIOBANK OF PATIENT-DERIVED XENOGRAFT MODELS FOR SARCOMA
Wei Sun
Favorite
Sun, Yutong

The University of Texas MD Anderson Cancer Center
(P 391) ATRX LOSS BLOCKS THE DIFFERENTIATION OF MESENCHYMAL STEM CELLS AND ADVANCES UNDIFFERENTIATED SARCOMA DEVELOPMENT
Yutong Sun
Favorite
Sun, Zhaoyu

Providence Cancer Institute
(P 58) PLK1 AS A VULNERABLE TARGET OF BAP1-DRIVEN UNDIFFERENTIATED PLEOMORPHIC SARCOMAS
Zhaoyu Sun
Favorite
Suraweera, Harini

Princess Margaret Cancer Centre, University Health Network and Mount Sinai Hospital
(P 210) TOWARDS INTERNATIONALIZATION OF THE CLINICAL RESEARCH COORDINATOR ROLE: THE FIRST DROP OF THE NIAGARA FALLS PROJECT
Harini Suraweera
Favorite
Sureshkumar, Keerthana

University of Miami Miller School of Medicine
(P 369) CLINICAL CHARACTERISTICS & TREATMENT OUTCOME PATTERNS OF SOLITARY FIBROUS TUMORS: A SINGLE-INSTITUTION RETROSPECTIVE ANALYSIS
Keerthana Sureshkumar
Favorite
Surrey, Lea

CHOP
(P 256) THE SEAN KARL COHORT: A NATIONAL COLLABORATIVE SINGLE-CELL RNASEQ STUDY OF PAIRED PATIENT EWING SARCOMA SPECIMENS
Lea Surrey
Favorite
Susic, Nikola

University of Miami Miller School of Medicine
(P 98) PERCUTANEOUS STABILIZATION OF METASTATIC BONE LESIONS WITH A PHOTODYNAMIC INTRAMEDULLARY SYSTEM: EXPERIENCE FROM A 15-PATIENT CASE SERIES
Nikola Susic
Favorite
(P 99) LIMB SALVAGE FOR PROXIMAL TIBIA TUMORS: OUTCOMES OF ALLOGRAFT-PROSTHESIS COMPOSITE AND ENDOPROSTHETIC RECONSTRUCTION
Nikola Susic
Favorite
(P 224) PAN-SARCOMA DATABASE (PSDB): AN UPDATE ON MIAMI'S COLLABORATIVE MULTI-USER DATA PIPELINE OF SARCOMA DATA USING REDCAP AND R CODING
Nikola Susic
Favorite
Suto, Hirotaka

Hyogo Cancer Center
(P 192) OPTIMAL DOSING SCHEDULE OF SUNITINIB BASED ON PLATELET COUNT IN AN OLDER PATIENT WITH GASTROINTESTINAL STROMAL TUMOR
Hirotaka Suto
Favorite
Sutton, Jeffrey

Division of Oncologic and Endocrine Surgery, Department of Surgery, Medical University of South Carolina
(P 279) IMPACT OF PREOPERATIVE 5-DAY HYPOFRACTIONATED RADIOTHERAPY (HFRT) FOR SOFT TISSUE SARCOMA (STS) ON BARRIERS TO TREATMENT AT A HIGH-VOLUME SARCOMA CENTER (HV-SC)
Jeffrey Sutton
Favorite
Suwan, Keittisak

Imperial College London
(P 116) A DUAL-TARGETED SYSTEMIC THERAPEUTIC APPROACH FOR THE SELECTIVE ELIMINATION OF TUMOR CELLS IN PRIMARY AND METASTATIC SARCOMA.
Keittisak Suwan
Favorite
Svane, Inge Marie

National Center for Cancer Immune Therapy, Department of Oncology, Herlev University Hospital
(P 249) IN VITRO EXPANSION OF TUMOR-INFILTRATING GAMMA-DELTA T-CELLS FROM PATIENTS WITH SOFT TISSUE SARCOMAS
Inge Marie Svane
Favorite
Swallow, Carol

Princess Margaret Cancer Centre, University Health Network and Mount Sinai Hospital
(P 210) TOWARDS INTERNATIONALIZATION OF THE CLINICAL RESEARCH COORDINATOR ROLE: THE FIRST DROP OF THE NIAGARA FALLS PROJECT
Carol Swallow
Favorite
(P 307) STRATEGIES FOR DATA QUALITY IN TARPSWG RETROPERITONEAL SARCOMA REGISTRY (RESAR)
Carol Swallow
Favorite
Swayambunathan, Jay

Duke University School of Medicine
(P 138) A MULTI-INSTITUTIONAL ARCHIVE AND DEEP LEARNING PIPELINE FOR QUANTIFYING CHONDROSARCOMA COMPOSITION
Jay Swayambunathan
Favorite
(P 177) DEEP LEARNING AND DIMENSIONALITY REDUCTION FOR SARCOMA SUBTYPING
Jay Swayambunathan
Favorite
Sweeney, Jackson

Stanley Manne Children's Research Institute
(P 252) NUCLEAR AND GENOMIC ORGANIZATION OF CHEMOTHERAPY RESISTANT RHABDOMYOSARCOMA CELLS
Jackson Sweeney
Favorite
Sweeney, Kyle

University of Kansas School of Medicine
(P 359) EVALUATION OF PREOPERATIVE MYXOFIBROSARCOMA GROWTH AND SURGICAL MORBIDITY AFTER NEOADJUVANT RADIATION USING SEMI-AUTOMATED VOLUMETRIC ANALYSIS
Kyle Sweeney
Favorite
(P 366) WOUND COMPLICATIONS AFTER ULTRA-HYPOFRACTIONATED NEOADJUVANT RADIATION FOR SOFT TISSUE SARCOMA: WHAT IS OPTIMAL SURGICAL TIMING?
Kyle Sweeney
Favorite
(P 382) METHOD FOR VOLUMETRIC ASSESMENT OF TUMOR RESPONSE FOLLOWING NEOADJUVANT RADIATION IN PRIMARY MYXOFIBROSARCOMA
Kyle Sweeney
Favorite
Sweet-Cordero, Alejandro

UCSF
(P 08) BUILDING A MEDICAL DONATION NETWORK TO ENHANCE DEVELOPMENT OF PEDIATRIC TUMOR MODELS
Alejandro Sweet-Cordero
Favorite
Swilling, Aubrey

University of Kansas Medical Center
(P 366) WOUND COMPLICATIONS AFTER ULTRA-HYPOFRACTIONATED NEOADJUVANT RADIATION FOR SOFT TISSUE SARCOMA: WHAT IS OPTIMAL SURGICAL TIMING?
Aubrey Swilling
Favorite
Switaj, Tomasz

Maria Sklodowska-Curie National Research Institute of Oncology
(P 470) OFF-LABEL TREATMENT AND ULTRARARE SARCOMAS - SINGLE INSTITUTION REPORT
Tomasz Switaj
Favorite
Syed, Sarosh

Sarcoma Oncology Center
(P 233) DNG64-CAR-V+ REGIMEN SHOWS CLINICAL BENEFIT IN PATIENTS WITH ADVANCED CCNG1 ONCOGENE EXPRESSING SARCOMAS (NCT04091295)
Sarosh Syed
Favorite
(P 388) TRIAL IN PROGRESS: A PHASE 2 STUDY OF METRONOMIC TRABECTEDIN, GEMCITIBAINE, AND DACARBAZINE IN PREVIOUSLY TREATED ADVANCED SOFT TISSUE SARCOMA (NCT04535271)
Sarosh Syed
Favorite
(P 396) EVALUATING THE SAFETY AND EFFICACY OF METRONOMIC GEMCITABINE, DOXORUBICIN, AND DOCETAXEL PLUS NIVOLUMAB IN PREVIOUSLY TREATED ADVANCED LEIOMYOSARCOMA AND LIPOSARCOMA: A PHASE 2 STUDY (NCT04535713)
Sarosh Syed
Favorite
(P 398) INVESTIGATING THE SAFETY AND EFFICACY OF LURBINECTEDIN WITH IPILIMUMAB AND NIVOLUMAB FOR ADVANCED SOFT TISSUE SARCOMA: LINNOVATE PHASE 1/2 STUDY (NCT05876715)
Sarosh Syed
Favorite
Symss, Nathan

University Health Network
(P 57) STUDYING HYPOXIA-INDUCED METASTASIS IN GENETICALLY ENGINEERED MOUSE MODELS OF UPS
Nathan Symss
Favorite
Szanto, Attila

Ipsen, Cambridge, MA, USA
(P 416) A PHASE 2 MULTICENTER OPEN-LABEL BASKET STUDY OF TAZEMETOSTAT IN ADULT PATIENTS WITH INI1-NEGATIVE EPITHELIOID SARCOMA – FINAL ANALYSIS
Attila Szanto
Favorite
Szepessy, Ava

Children's Hospital of Philadelphia
(P 262) EVALUATING FRONT-LINE THERAPY ACCORDANCE WITH CURRENT SYNOVIAL SARCOMA GUIDELINES
Ava Szepessy
Favorite
(P 263) DESCRIBING THE CHARACTERISTICS AND TREATMENT OF SYNOVIAL SARCOMA IN THE RECURRENT SETTING
Ava Szepessy
Favorite
Szostakowski, Bartłomiej

Maria Sklodowska-Curie National Research Institute of Oncology; Warsaw Poland
(P 123) OFF-LABEL DENOSUMAB IN LOCALLY AGGRESSIVE BENIGN BONE TUMORS OTHER THAN GIANT CELL TUMOR OF BONE.
Bartłomiej Szostakowski
Favorite
(P 216) VIRTUAL MULTIDISCIPLINARY MEETINGS IN THE CARE OF SARCOMA PATIENTS
Bartłomiej Szostakowski
Favorite
Szostakowski, Bartlomiej

Maria Sklodowska-Curie National Research Institute of Oncology
(P 149) SURGICAL TEXTBOOK OUTCOMES IN PATIENTS DIAGNOSED WITH CHONDROSARCOMA
Bartlomiej Szostakowski
Favorite
(P 164) LONG TERM OUTCOMES IN PATIENTS DIAGNOSED WITH SECONDARY CHONDROSARCOMA
Bartlomiej Szostakowski
Favorite
Szumera-Cieckiewicz, Anna

Maria Sklodowska-Curie National Research Institute of Oncology
(P 27) MOLECULAR CHARACTERIZATION OF RESPONSE TO NEOADJUVANT CHEMORADIATION IN PATIENTS WITH LOCALLY ADVANCED SOFT TISSUE SARCOMAS
Anna Szumera-Cieckiewicz
Favorite
(P 139) IMMUNOGENOMIC PROFILING OF CHONDROSARCOMA REVEALS DISTINCT IMMUNE PHENOTYPES AND PROGNOSTIC MUTATIONS
Anna Szumera-Cieckiewicz
Favorite